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Brain organoids, three-dimensional cultures that model organogenesis, provide a 
new platform to investigate brain development. High cost, variability and heterogeneity 
currently limit the broad application of existing brain organoid technologies. My thesis 
work focuses on developing methods to generate forebrain organoids from human 
induced pluripotent stem cells (hiPSCs) using a custom-designed spinning bioreactor. 
Forebrain organoids recapitulate key features of human cortical development, including 
progenitor zone organization, neurogenesis, gene expression, and, notably, a well-defined 
outer radial glial cell (RGCs) layer resembling the human outer subventricular zone.  
An immediate application for brain organoids is to address the global health 
emergency of Zika virus (ZIKV)-induced microcephaly. Exposure of ZIKV to forebrain 
organoids revealed preferential, productive infection of RGCs. ZIKV infection leads to 
increased cell death and reduced proliferation, resulting in decreased neuronal cell layer 
volume and reduced overall organoid size, resembling microcephaly. Our forebrain 
organoids and SpinΩ bioreactor provide an accessible and versatile platform for 
modeling human brain development and disease, and for compound testing, including 
potential ZIKV antiviral drugs. Results from our ZIKV experiments reveal cellular 
mechanisms of ZIKV-induced microcephaly and have implications for therapeutic 
development.  
Another limitation of current organoid methods is interior hypoxia and cell death 
due to insufficient surface diffusion, preventing generation of architecture representative 
iii 
 
of late developmental stages. In order to generate more mature organoids, we developed 
the sliced neocortical organoid (SNO) method, which bypasses the diffusion limit to 
prevent cell death over long-term cultures. This method leads to sustains neurogenesis 
and formation of an expanded cortical plate that establishes distinct upper and deep 
cortical layers for neurons and astrocytes, resembling the third-trimester embryonic 
human neocortex. Using the SNO system, we further identify a critical role of WNT/β-
Catenin signaling in regulating cortical neuron fate specification, which is disrupted by a 
psychiatric disorder-associated genetic mutation in patient iPSC-derived SNOs. These 
results demonstrate the utility of SNOs as a model for investigating previously 
inaccessible human-specific late-stage cortical development and disease-relevant 
mechanisms.  
Together, my work has tremendously advanced brain organoid technologies, and 
provided a novel platform to elucidate the underlying mechanisms and potential 
therapeutic strategies for neurodevelopmental diseases. 
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1- General Introduction 
Human induced pluripotent stem cells (iPSCs) can generate virtually any cell type 
in the body and are being used to model human development and diseases, to screen for 
drugs, and to develop new cell replacement therapies. Significant progress has been made 
in developing methodologies for targeted differentiation of human iPSCs into various cell 
types, including cells in the nervous system (Liu and Zhang, 2011; Petros et al., 2011). 
Traditionally, monolayer 2D cultures are used for better external control and to produce 
more uniform cell populations; however, they lack properties of 3D cell assembly that 
define endogenous biological systems. Structures resembling whole developing organs, 
named organoids, have recently been generated from human iPSCs via 3D cultures and 
include intestinal, kidney, retinal, and cerebral organoids (Lancaster and Knoblich, 
2014b; Sasai, 2013; Sato and Clevers, 2013; Yin et al., 2016). Organoid technology 
evolved from cultures of embryoid bodies, which are 3D aggregates of stem cells that 
self-organize to develop disparate tissues in vitro, similar to teratoma formation in vivo. 
Organoids provide a unique opportunity to model organ development in a culture system 
that is remarkably similar to human organogenesis in vivo, which is not accessible to 
experimentation. One example would be using cerebral organoids to address the current 
global public health emergency concerning a suspected link between Zika virus (ZIKV) 
infection and microcephaly (Heymann et al., 2016).  
One recent major advance in cerebral organoid technology was the use of a 
spinning bioreactor to facilitate nutrient and oxygen absorption, which enables formation 
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of longer continuous neuroepithelial-like zones and growth of large, complex organoids 
that more closely resemble the human brain than previous studies (Lancaster et al., 2013). 
Derived from the early NASA-designed rotating wall vessel bioreactor to simulate 
microgravity, this technology potentially offers two additional benefits: low fluid shear 
stress to promote cell-cell interactions and initiation of differentiation signaling 
(Goodwin et al., 1993); and randomized gravitational vectors that affect intracellular 
signal transduction and gene expression (Jessup et al., 1993). This and other pioneering 
human cerebral organoid technologies (Kadoshima et al., 2013a; Lancaster et al., 2013; 
Mariani et al., 2015; Muguruma et al., 2015; Pasca et al., 2015) have generated 
substantial excitement for using organoids to model human brain development and 
disorders (Bae and Walsh, 2013; Bershteyn and Kriegstein, 2013; Chambers et al., 2013; 




2 – General Methods 
2.1 - Maintenance of Human iPSCs 
Human iPSC lines used in the current study were previously fully characterized 
(Wen et al., 2014; Yoon et al., 2014). They were cultured in stem cell medium consisting 
of DMEM:F12 (Invitrogen) supplemented with 20% Knockout Serum Replacer (Gibco), 
1X Non-essential Amino Acids (Invitrogen), 1X Penicillin/Streptomycin, 1X 2-
Mercaptoenthanol (Millipore), 1X Glutamax (Invitrogen), and 10 ng/mL FGF-2 as 
previously described (Yoon et al., 2014). Culture medium was changed every day. iPSCs 
were passaged every week onto a new plate pre-seeded with irradiated CF1 mouse 
embryonic fibroblasts (Charles River). iPSCs were detached from the plate by treatment 
of 1 mg/mL Collagenase Type IV (Invitrogen) for 1 hr. iPSC colonies were further 
dissociated into smaller pieces by manual pipetting. All studies were performed with 
approved protocols of Johns Hopkins University School of Medicine. 
2.2 - Tissue Preparation and Immunohistochemistry 
Whole organoids were fixed in 4% Paraformaldehyde in Phosphate Buffered 
Saline (BPS) for 30-60 min at room temperature. Organoids were washed 3 times with 
PBS and then incubated in 30% sucrose solution overnight. Organoids were embedded in 
freezing medium and sectioned with a cryostat (Leica). For immunostaining, freezing 
medium was washed with PBS before permeabilization with 0.2% Triton-X in PBS for 1 
hr. Tissues were blocked with blocking medium consisting of 10% donkey serum in PBS 
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with 0.1% Tween-20 (PBST) for 30 min. Primary antibodies diluted in blocking solution 
were applied to the sections overnight at 4ºC. After washing with PBST, secondary 
antibodies diluted in blocking solution were applied to the sections for 1 hr at room 
temperature. Finally, the sections were washed with PBST and stained with DAPI. All 
images were captured by a confocal microscope (Zeiss LSM 700). For paraffin-
embedded human samples, slides were first deparaffinized and retrieved using sodium 




3 - Establishing the brain region-specific organoid systems as models for human brain 
development 
(This chapter was published(Qian et al., 2016). I am the first author and was involved in 
all aspects of the study.) 
 
3.1 – Introduction 
The rapidly advancing field of stem cell biology continually provides new 
insights into basic biology and human disorders and drives innovation for new patient 
treatments. In the past 10 years, human induced pluripotent stem cells (iPSCs) have 
emerged as an invaluable tool in modeling human disorders, especially those with 
complex genetic origins that are challenging to model in animals (Takahashi et al., 2007; 
Wen et al., 2016). IPSCs are somatic cells that have been reprogrammed into a 
pluripotent stem cell state, similar to embryonic stem cells.  Under specific cues and 
favorable conditions, iPSCs can theoretically be differentiated into any cell or tissue 
types found in the human body. A new frontier of stem cell research is to generate three-
dimensional (3D) tissue structures to model organogenesis and developmental disorders. 
Brain organoids are human pluripotent stem cell-derived 3D tissues that self-assemble 
into organized structures resembling the fetal human brain (Jo et al., 2016; Kadoshima et 
al., 2013a; Lancaster et al., 2013; Mariani et al., 2015; Pasca et al., 2015; Qian et al., 
2016). Unlike conventional 2D cell cultures, organoids recapitulate human organogenesis 
not only at the cellular level, but also in architecture and developmental trajectory, 
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therefore providing a unique opportunity to model human organogenesis, which is not 
accessible to direct experimentation.  
Despite the promise inherent in these pioneering organoid technologies, we are at 
the very beginning of an era to engineer human brain models. First, currently available 
spinning bioreactors require a large volume of culture medium and incubator space. With 
frequent medium changes over several months of culturing, the system is cost-prohibitive 
for a majority of laboratories to maintain and precludes scalability, use of expensive 
growth factors, or screening of chemical compounds. It also presents a major roadblock 
for testing multiple conditions to optimize protocols. Second, the current cerebral 
organoid method (“intrinsic protocol”) is based on self-assembly of cells without external 
control, and each organoid is comprised of heterogeneous cell types found in forebrain, 
hindbrain, and retina (Lancaster et al., 2013). Large sample to sample variability for all 
current technologies make quantitative analysis challenging and limit their broad 
applications. Third, some key features of human brain development have yet to be 
recapitulated in a robust manner in cerebral organoids reported so far. For example, 
unlike rodents, the embryonic human cerebral cortex contains an abundant population of 
specialized outer radial glia cells (oRGCs) in the outer subventricular zone (oSVZ) that 
are believed to contribute significantly to the evolutionary increase in the size and 
complexity of human cortex (Dehay et al., 2015; Lui et al., 2011; Taverna et al., 2014). 
Cerebral organoids generated with existing protocols contain only sparse progenitors with 
morphological characteristics of oRGCs and none have exhibited a well-developed oSVZ 
layer (Kadoshima et al., 2013a; Lancaster et al., 2013; Mariani et al., 2015; Pasca et al., 
2015). Taken together, there is a critical need to develop an organoid platform with 
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drastically reduced cost and higher throughput, increased reproducibility and minimal 




3.2 - Methods 
3.2.1 - Bioreactor Design, Printing and Assembling  
We used SolidWorks for design and drawings of all parts, including spinning 
sleeves and shafts (CAD files to be deposited in the public domain). Cover units were 
designed to fit a standard 12-well culture plate. Autoclavable plates and spinning shafts 
were printed with a 3D printer (Fortus 450mc) using ULTEM 9085, and other parts were 
printed using polycarbonate. Standalone spinning bioreactors were assembled from parts 
consisting of IG16 6VDC 051 RPM Gear Motor (SuperDroid Robots TD-060-051), gears 
(GR.MOLD.SP.M0.5 (US); SDP/SIA 1Z 2MYZ0505206), sleeve bearings (Metric PTFE 
Sleeve Bearing, for 6 mm Shaft Diameter, 12 mm OD, 10 mm Length; McMaster-Carr 
2685T11), Aluminum Unthreaded Spacers (1/4" OD, 3/4" Length, #4 Screw Size; 
McMaster-Carr 92510A308), and power supply (Hosa Cable ACD477 Universal AC 
Power Supply; Amazon). The modular individual bioreactors were made to fit into a 
stackable bioreactor with some modifications. All gears in the stackable bioreactor were 
driven by a more powerful motor (IG32 Right Angle 12VDC 043 RPM Gear Motor; 
SuperDroid Robots TD-035-043) connected to a series of shaft couplings (Rigid, 
Setscrew; Misumi CPR16-6-6), rotary shafts (D Cut; Misumi SSFRV6-55-F19-T12), 
bearings (Single Row, Metric Sizes, Acetal Plastic Radial Ball Bearings fitted with Glass 
Balls; KMS Bearings A626-G), and gears (Module 0.5, 96 Teeth, 20° Pressure Angle, 




3.2.2 - Culture of Forebrain Organoids from Human iPSCs 
To generate forebrain-specific organoids, human iPSC colonies were detached 
with Collagenase Type IV 7 days after passage, washed with fresh stem cell medium and 
cultured in a 15 ml conical tube. On day 1, detached and washed iPSC colonies were 
transferred to an Ultra-Low attachment 6-well plate (Corning Costar), containing 3 ml of 
stem cell medium (without FGF-2), plus 2 M Dorsomorphine (Sigma) and 2 M A83-
01 (Tocris). On days 5-6, half of the medium was replaced with induction medium 
consisting of DMEM:F12, 1X N2 Supplement (Invitrogen), 10 g/ml Heparin (Sigma), 
1X Penicillin/Streptomycin, 1X Non-essential Amino Acids, 1X Glutamax, 4 ng/ml 
WNT-3a (R&D Systems), 1 M CHIR99021 (Cellagentech), and 1 M SB-431542 
(Cellangentech). On day 7, organoids were embedded in Matrigel (BD Biosciences) and 
continued to grow in induction medium for 6 more days. On day 14, embedded organoids 
were mechanically dissociated from Matrigel by pipetting up and down onto the plate 
with a 5 ml pipette tip. Typically, 10 - 20 organoids were transferred to a 12-well 
spinning bioreactor (SpinΩ) containing differentiation medium consisting of 
DMEM:F12, 1X N2 and B27 Supplements (Invitrogen), 1X Penicillin/Streptomycin, 1X 
2-Mercaptoenthanol, 1X Non-essential Amino Acids, 2.5 g/ml Insulin (Sigma). At day 
71, differentiation medium was exchanged with maturation medium consisting of 
Neurobasal (Gibco), 1X B27 Supplement, 1X Penicillin/Streptomycin, 1X 2-
Mercaptoenthanol, 0.2 mM Ascorbic Acid, 20 ng/ml BDNF (Peprotech), 20 ng/ml GDNF 
(Peprotech), 1 ng/ml TFG  (Peprotech), and 0.5 mM cAMP (Sigma). The organoids 
could grow beyond 110 days in maturation medium. All media were changed every other 
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day. For the stationary culture, day 14 organoids were generated following the same 
protocol above and were maintained in non-attaching 6 well plate with differentiation 
media. The intrinsic protocol for spontaneous differentiation of human iPSCs into 
cerebral organoids followed the published protocol (Lancaster et al., 2013). 
3.2.3 - Culture of Midbrain Organoids from Human iPSCs  
To generate midbrain-specific organoids, human iPSC colonies were detached 
with Collagenase Type IV 7 days after passage and washed with fresh stem cell medium 
in a 15 ml conical tube. On day 1, the detached and washed iPSC colonies were 
transferred to an Ultra-Low attachment 6-well plate containing EB medium consisting of 
DMEM:F12, 15% Knockout Serum Replacer, 1X Glutamax, 1X 2-Mercaptoenthanol, 
100 nM LDN-193189, 10 M SB-431542, 100 ng/ml SHH (Peprotech), 2 M 
Purmorphamine (Stemgent), 100 ng/ml FGF-8 (Peprotech). On day 5, EB medium was 
gradually switched to SHH medium consisting of DMEM:F12, 1X N2 Supplement, 1X 
Glutamax, 100 nM LDN-193189, 3 M CHIR99021, 100 ng/ml SHH, 2 M 
Purmorphamine, 100 ng/ml FGF-8. On day 7, SHH medium was replaced with induction 
medium consisting of DMEM:F12, 1X N2 Supplement, 1X Glutamax, 100 nM LDN-
193189, 3 M CHIR99021. On day 14, 10-20 organoids were transferred to SpinΩ with 
differentiation medium consisting of Neurobasal, 1X B27 Supplement, 1X Glutamax, 1X 
2-Mercaptoenthanol, 20 ng/ml BDNF, 20 ng/ml GDNF, 0.2 mM Ascorbic Acid, 1 ng/ml 




3.2.4 - Culture of Hypothalamus Organoids from Human iPSCs 
To generate hypothalamus-specific organoids, human iPSC colonies were 
detached with Collagenase Type IV after 7 days following passaging and washed with 
fresh stem cell medium in a 15 ml conical tube. On day 1, the detached and washed iPSC 
colonies were transferred to an Ultra-Low attachment 6-well plate (Corning Costar) 
containing stem cell medium. One day after (day 2), stem cell medium was replaced with 
induction medium A consisting of DMEM:F12, 10% Knockout Serum Replacer, 1X 
Non-essential Amino Acids, 1X Penicillin/Streptomycin, 1X 2-Mercaptoenthanol, 1X 
Glutamax, 2.5 M LDN-193189 (Stemgent), 3 M SB-431542, and 450 M 1-
Thioglycerol (Sigma). On day 4, the medium was switched to induction medium B 
consisting of DMEM:F12, 10% Knockout Serum Replacer, 1X Non-essential Amino 
Acids, 1X Penicillin/Streptomycin, 1X Glutamax, 1X N2 Supplement, 10 ng/m Wnt-3A, 
20 ng/ml SHH, and 2 M Purmorphamine. On day 7, 5-10 organoids were transferred to 
a 12-well spin bioreactor and induction medium B was replaced with differentiation 
medium consisting of DMEM:F12/Neurobasal (1:1 ratio), 1X B27 Supplement, 1X Non-
essential Amino Acids, 1X Penicillin/Streptomycin, 1X Glutamax, 10 ng/ml FGF-2 and 
10 ng/ml CTNF (Peprotech). All media were changed every other day. 
3.2.5 - BPA Treatment Experiment 
Forebrain organoids were grown using protocol described above. For long-term 
BPA treatment experiments, forebrain organoids at day 14 from the same batch were 
distributed randomly into separate wells within SpinΩ and treated with corresponding 
concentrations of BPA (Sigma). BPA was dissolved in sequential dilution in 
differentiation media with 0.05% methanol, which was also added in the control 
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condition. Media containing BPA was replaced every other day until day 28 for analysis. 
A previous study determined that tissue culture plates do not contain detectable BPA 
(Biswanger et al., 2006). Quantification was conducted by investigators blind to culture 
conditions.  
For acute BPA treatment experiment, forebrain organoids were grown to day 28 
and treated with corresponding concentration of BPA for 24 hours. At day 29, the culture 
media was replaced with fresh media and washed 3 times to remove residual BPA. 
Organoids were then pulsed with 10 μM EdU for 2 hr. The media were then replaced and 
organoids were washed 3 times with fresh media. At day 30, organoids were fixed for 
immunohistochemistry and EdU detection using Click-iT® EdU Alexa Fluor® 488 
Imaging Kit (ThermoFisher C10337) according to the manufacturer’s manual, followed 
by immunostaining for SOX2 and PH3. Imaging was acquired in Zeiss LSM 700 
Confocal system at 25x magnification. Quantification was performed by counting the 
number of EdU and PH3+ nuclei within SOX2+ ventricular structures that were 
recognized by neural tube-like morphology. EdU and PH3 densities were normalized to 
the area of ventricular structures measured in ImageJ software. Quantification was 
conducted by investigators blind to culture conditions.  
 
3.2.6 - Quantification of Cell Fates and Layer Thickness  
For cell fate quantifications, organoids grown from the intrinsic protocol and 
forebrain protocol were immunostained for SOX2, PAX6 and OTX2 at day 14. Images 
were acquired with Zeiss Axiovert 200M fluorescent microscope. Neural tube structures 
were counted as positive for forebrain markers when more than 80% of all nuclei were 
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positive for respective markers. Markers for different brain regions (FOXA2, NKX2.1 
and PROX1) were quantified by measuring the area stained positive for markers and 
normalized to DAPI in ImageJ software.  
Organoids grown from the intrinsic protocol and forebrain protocol were 
immunostained for SOX2, TUJ1 and CTIP2 at day 14 and 28. The ventricular-like zone 
(VZ) was defined by SOX2 immunoreactivity and neural-tube morphology and the outer 
layer was defined by the area outside the VZ to the nearest pial surface. For each 
ventricular structure, 3 measurements were performed forming a right-angle fan area 
pointing to the nearest pial surface, at 0, 45 and 90 degrees. The length for VZ and outer 
layer was measured in ImageJ software. The relative VZ thickness was defined as the 
ratio of VZ thickness to VZ plus outer layer thickness. Layer thickness measurements at 
day 56 and 85 in forebrain organoids were performed similarly as described above with 
the addition of SVZ. The SVZ was defined by the region within mixed population of 
SOX2+ and CTIP2+ nuclei outside the VZ. The cortical plate (CP) was defined by the 
region from the boundary of SVZ to the pial surface within exclusive CTIP2+ nuclei. 
Relative thicknesses for VZ, SVZ and CP were calculated by the ratio to total thickness 
from ventricular to pial surface.  
3.2.7 - RNA-Seq and Bioinformatic Analysis 
Forebrain organoids at days 26, 40, 54 and 100 (three samples for the first three 
time points and two samples for day 100) were collected and processed for RNA-seq and 
bioinformatics analyses as previously described (Guo et al., 2014).  
Sequence read counts for 22 different human fetal organs were obtained from 
GSE66302. The sequences were aligned to UCSC hg19 reference genome using Bowtie 
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(Langmead and Salzberg, 2012), and the read counts were obtained using 
R/Bioconductor (Gentleman et al., 2004). Human dorsolateral prefrontal cortex RNA-seq 
datasets (RPKM values) from six different life stages were obtained from (Jaffe et al., 
2015) (http://www.nature.com/neuro/journal/v18/n1/extref/nn.3898-S9.zip). RNA-seq 
gene expression (RPKM) for 11 time points of fetal development and 16 different brain 
regions were obtained from Allen Brain Atlas (http://www.brain-map.org/). All gene 
expression values are summarized as the log RPKM values against the Ensembl gene 
annotation.   
To assess the correlations of gene expressions between organoids from the current 
study and fetal organs, we first select genes with moderately high average expression 
levels and variance. Briefly, we only used genes with average expression levels greater 
than three and variance greater than one from fetal organs. These genes show marked 
differences among organs and thus are more informative than using all genes in the 
correlation analysis. Pearson correlations were computed based on expression of these 
genes. Correlations were averaged for biological replicates show all the correlation 
values. We found that the patterns of correlation were stable against the gene selection 
criteria. Thresholds used for selecting genes, albeit arbitrary, had very little impact on the 
final results. The same strategy was used to compute the correlations between organoid 
and other samples (brains at different developmental stages and regions).  
Differentially expressed genes between D26 and late stages of organoids were 
defined as genes with absolute log fold changes of RPKM greater than one, and the 
average base line expression (log RPKM) greater than 2. Schizophrenia-related risk genes 
were obtained from Schizophrenia Gene Resource (SZGR) 
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(http://bioinfo.mc.vanderbilt.edu/SZGR/). Autism-related risk genes were obtained from 
Simons Foundation Autism Research Initiative (SFARI) 
(https://gene.sfari.org/autdb/HG_Home.do). The significance of gene overlap was 
assessed by chi-squared test on 2-by-2 tables.  
R programming language was used to perform all data analysis and generate the 
figures.  
3.2.8 - Electroporation 
Organoids at day 50 were transferred into Petri dish containing PBS, and 2 l of 
GFP expressing plasmid (pCAGGS-eGFP, 2 g/ l, diluted in sterile PBS with 0.01% 
fast green) was injected into 3-4 locations within an organoid using a beveled and 
calibrated micropipette. Five pulses (40 V, 50 ms in duration with a 950 ms interval) 
were delivered with tweezer electrodes (CUY650-5, Nepa Gene) by a CUY21SC 
electroporator (Nepa Gene) as previously described (Yoon et al., 2014). Electroporated 
organoids were transferred back to SpinΩ and cultured until fixation.  
3.2.9 - Electrophysiology 
Organoid slices were prepared by embedding organoids in 4% low melting point 
agarose cooled to approximately 32°C. Slices (250 µm) were sectioned using a vibratome 
(Microm HM650V) and stored at room temperature, oxygenated (95% 02, 5% CO2) 
artificial cerebrospinal fluid (ACSF) containing (in mM): 125 NaCl, 25 NaHCO3, 1.25 
NaH2PO4, 3 KCl, 25 dextrose, 1 MgCl2, and 2 CaCl2, pH 7.3. Slices were immediately 
ready for recording. 
 
16 
For all experiments, ACSF was oxygenated (95% O2, 5% CO2) and bath 
temperature was approximately 38°C. Patch pipettes were fabricated from borosilicate 
glass (N51A, King Precision Glass, Inc.) to a resistance of 2-5 MΩ. For current- and 
voltage-clamp measurements pipettes were filled with (in mM): 125 potassium gluconate, 
10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 0.1 EGTA, 10 phosophocreatine, 0.05%, adjusted to 
pH 7.3 with KOH. For all experiments GABAA receptors were blocked with SR-95531 
(Gabazine, 5 µM, Abcam). In sEPSC experiments, synaptic currents were blocked with 
6,7-Dinitroquinoxaline-2,3-dione (DNQX, 10µM, Abcam). Sodium currents and action 
potentials were blocked with tetrodotoxin (TTX, 300 nM, Abcam). Current signals were 
recorded with either an Axopatch 200B (Molecular Devices) or a Multiclamp 700A 
amplifier (Molecular Devices) and were filtered at 2 kHz using a built in Bessel filter and 
digitized at 10 kHz. Voltage signals were filtered at 2 kHz and digitized at 10kHz. Data 
were acquired using Axograph on a Dell PC (Windows 7). For voltage clamp recordings, 
cells were held at -70 mV. 
3.2.10 - Calcium Imaging Analysis 
Calcium imaging was performed similarly as previously described (Kim et al., 
2012). Organoids were loaded with Fluo-4 (Life Technologies) for 30 min before the start 
of imaging. Throughout experiments, oxygenated aCSF was continuously perfused at a 
rate of 3 ml/min at room temperature (25 ± 2°C). Glutamate and GABA were added to 
media during imaging sessions at a final concentration of 20 μM and 10μM, respectively. 
Bicuculline was added by bath application to media during imaging at a final 
concentration of 50 μM and imaging was resumed after a 15-min incubation time. Cells 
were excited at 488 nm, and Fluo-4 signal was collected at 505–550 nm. Images were 
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acquired and analyzed using NIH Image J software. The Ca2+ signal change was 
determined by ΔF/F [ΔF/F = [(F1-B1)-(F0-B0)]/(F0-B0)], which was normalized to the 




3.3 - Results 
3.3.1 - A Miniaturized Spinning Bioreactor to Optimize Organoid Cultures from Human 
iPSCs 
To drastically reduce the cost for culturing organoids under each condition, we 
attempted to miniaturize the large spinning flask. Because of differences in fluid 
dynamics, we could not simply proportionally scale down the system in size. Instead, we 
engineered a multi-well spinning device to fit a standard 12-well tissue culture plate 
(Figure 1A). Above the cover, spin shafts are attached to a set of 13 interconnecting 
gears, driven by a single electric motor for synchronous rotation (Figure 1A). We used 
Computer-Aided Design software Solidworks to design and 3D print each component, 
including the spinning shaft and leaf, and plate cover. We assembled prototypes to 
optimize fluid dynamics that sustains organoids of varying sizes in suspension under 
moderate spinning speed, and prevents organoid aggregation underneath the shaft at the 
center of each well. After multiple rounds of systematic optimization of individual 
components, including number, shape, size and angle of leaves, and diameter, length and 
shape of shaft, we arrived at SpinΩ, a miniaturized spinning bioreactor unit that requires 
as little as 2 ml of medium per well, a 50-fold reduction in medium consumption and 
drastically reduced incubator space. We further designed a stackable version with 
insertable cassettes to be driven by one common motor. The miniaturized spinning 
bioreactor permits comparisons of a large number of conditions in parallel for protocol 
optimization to achieve minimal variability and high reproducibility. 
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To reduce the tissue heterogeneity observed in cerebral organoids generated by 
the “intrinsic protocol” (Lancaster et al., 2013), we pre-patterned embryoid bodies to the 
fate of a specific brain region. Based on our recently developed protocol for 2D 
differentiation of human iPSCs into forebrain-specific cortical neural progenitor cells 
(NPCs) (Wen et al., 2014), we first treated human iPSCs with dual SMAD inhibitors 
(dorsomorphin and A-83) for 7 days and then embedded embryoid bodies in Matrigel for 
another 7 days, followed by Matrigel removal and spinning in Spin (Figure 1B). 
Compared to the “intrinsic protocol”, we could reliably generate organoids from multiple 
iPSC lines with reduced heterogeneity in organoid shape and size. However, there was 
significant cell death within organoids as shown by activated caspase-3 immunostaining. 
We then tested combinations of different signaling molecules for various durations. We 
found that treatment with three factors, GSK-3 inhibitor CHIR99021, recombinant 
Wnt3A protein, and SMAD inhibitor SB-431542, during the Matrigel stage drastically 
reduced numbers of activated caspase-3+ cells within organoids at day 14. Later we found 
that Wnt3A contribution was minimal, likely because Wnt3A and CHIR99021 activate 
the same downstream signaling pathway. Notably, nearly all cells within organoids self-
assembled into organized neuroepithelial tissue at this stage and individual 
neuroepithelial structures were consistently much larger than those generated without 
treatment of these factors. At day 14, well-defined polarized neuroepithelium-like 
structures resembled neural tubes in embryonic development, with a pure population of 
NESTIN+SOX2+ NPCs, and expression of adherent junction markers (-CATENIN and 
PKC) and proliferation marker phospho-Histone H3 (PH3) localized exclusively at the 
ventricular surface (Figure 1C). Upon spinning in SpinΩ, these organoids developed into 
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multi-layer stratified structures, composed of SOX2+ NPCs, TBR2+ intermediate 
progenitor cells (IPCs) and CTIP2+ neuron layers (Figure 1D). With the small volume of 
culture medium required, it became affordable to supplement with growth factors, such as 
BDNF, GDNF and TGF, at later stages to promote survival, neuronal maturation and 
expansion of cortical layer sizes (Figure 1B).  
As comparisons, we followed the same protocol but maintained organoids in 
stationary culture after day 14. At day 42, there was substantial cell death in the interior 
of organoids as shown by activated caspase-3 immunostaining. In addition, ventricular 
structures were largely absent in these organoids; instead, extensive neurogenesis without 
defined organization was observed. We also cultured our forebrain organoids using 
orbital shakers (Lancaster and Knoblich, 2014a). Under a similar rotation speed that we 
used for spinning in SpinΩ, shaking generated rotational movements causing organoids 
to roll on the culture plate bottom. At day 42, organoids showed substantial cell death in 
the neuronal layer despite retaining defined ventricular structures. After day 50, many of 
these organoids disintegrated. These results suggest that spinning cultures enhance cell 
viability and promote maintenance of the stem cell niche at least for forebrain organoids 
generated using our protocol. The miniaturized spinning bioreactor platform opens doors 
for cost-effective generation of organoids from human iPSCs and provides access and 








Figure 1. SpinΩ Bioreactor-based Forebrain Organoid Culture System. 
(A) Computer-Aided-Design (CAD) drawings of the 12-well version SpinΩ bioreactor 
and individual parts. 
(B) Schematic diagram of the protocol for generating forebrain organoid and sample 
phase images at different stages. Scale bars: 100 µm (Day 8 – 25) and 500 µm (Day 71 
and 80). See Experimental Procedures for details. Dorso: Dorsomorphin (2 M); A83: 
A-83-01 (2 M); CHIR: CHIR99021 (1 M); SB: SB-431542 (1 M); B27: B27 
supplement; N2: N2 supplement; NB: Neurobasal medium; GDNF: Glial cell-derived 
neurotrophic factor (20 ng/ml); BDNF: Brain-derived neurotrophic factor (20 ng/ml); 
TGFβ: Transforming growth factor beta (1 ng/ml); cAMP: cyclic adenosine 
monophosphate (0.5 mM).   
(C) Immunostaining of neuroepithelium-like tissue formed at day 14 for adherent 
junction markers (β-Catenin and PKCλ), neural progenitor cell (NPC) markers (SOX2 
and Nestin). Neuroepithelium-like tissue exhibits apical-basal polarity with the apical 
surface identified by PKCλ expression and PH3+ cells undergoing mitosis. Scale bars: 
100 µm. 
(D) Immunostaining of forebrain organoids at day 63 (left) and 84 (right) for the NPC 
marker (SOX2), intermediate progenitor cell (IPC) marker (TBR2) and cortical neuron 
marker (CTIP2).   




3.3.2 - Organoids with a Forebrain Identity and Increased Homogeneity 
We next performed detailed characterization of early stage forebrain organoids 
produced in Spin (Figure 1B). At day 14, immunohistological analysis showed almost 
exclusive expression of forebrain-specific progenitor markers, including PAX6, OTX2 
(Figure 2A) and FOXG1, with minimal expression of markers for other brain regions 
tested. We obtained similar results with multiple iPSC lines and with different clones of 
the same iPSC lines (Figure 2A). Consistent with previous findings, cerebral organoids 
generated in large spin flasks using the “intrinsic protocol” exhibited diverse brain region 
identities with less than 50% of rosettes expressing forebrain markers PAX6 or OTX2 
(Figure 2A).  
We further assessed the temporal homogeneity of neuronal differentiation via 
quantification of the relative thickness of the SOX2+ ventricular zone-like (VZ) layer and 
the TUJ1+ neuronal layer between apical and basal surfaces (Figure 2B). At day 14, 
organoids generated using the “intrinsic protocol” exhibited varying degree of 
neurogenesis, whereas very few neuronal progenies were detected in forebrain organoids. 
As a result, our protocol produced organoids with nearly 100% of cells organized as the 
VZ layer, compared to significant variability using the “intrinsic protocol” (Figure 2B). 
By day 28, we observed both a SOX2+ progenitor layer and a TUJ1+/CTIP2+ neuronal 
layer (Figure 2C). Forebrain organoids further exhibited a consistent ratio between 
progenitor and neuronal layers, compared to the large variability using the “intrinsic 
protocol” (Figure 2D). These quantitative analyses indicate that forebrain organoids 
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exhibit markedly enhanced homogeneity, in term of both brain region identity and timing 
of differentiation.    
The apparent homogeneity of forebrain organoids, small medium volume per 
condition and multi-well format of Spin comprise a platform amenable to chemical 
compound testing. As a proof-of-principle, we tested the effect of Bisphenol A (BPA), 
which is commonly found in household plastic products and has been shown to affect 
rodent neural development (Kinch et al., 2015; Kundakovic et al., 2013; Mathisen et al., 
2013). We treated forebrain organoids from day 14 to 28 with a range of concentrations 
of BPA and observed a dose-dependent decrease in the relative VZ thickness at day 28 
(Figure 2E-F). To explore potential underlying cellular mechanism, we treated forebrain 
organoids acutely with a range of higher concentrations of BPA for 24 hours and then 
pulse-labeled proliferating cells with EdU. Quantitative analysis showed a dose-
dependent decrease in the density of EdU+ or PH3+ NPCs, suggesting that reduced NPC 








Figure 2. Homogeneity of Early Stage Forebrain Organoids and Effects of BPA.  
(A) Sample images and quantification among multiple iPSC cell lines and clones for 
immunostaining of forebrain progenitor marker (Pax6 and OTX2) in neural tube-like 
structures generated from either the forebrain or the “intrinsic protocols” at day 14. 
Scale bars: 100 µm. Values represent mean ± SEM (42- 128 total neural tube structures 
for the forebrain protocol and 11- 30 total neural tube structures for the intrinsic 
protocol from at least 10 organoids each; *P < 0.05, Student’s t-test).  
(B) Schematic drawing for SOX2+ ventricular zone (VZ) and TUJ1+ neuronal layer 
measurement in cortical structures (top panel) and box plot for relative VZ thickness in 
day 14 organoids generated using forebrain and intrinsic protocols (Bottom panel). For 
each cortical structure, three measurements were taken at 45 degree angles to obtain the 
mean value. Relative VZ thickness= ratio of VZ thickness to total thickness from 
ventricular surface to pial surface. See Experimental Procedures for details. The red dot 
indicates mean; upper and lower error bars in each box plot represent the top whisker 
(maximum value) and bottom whisker (minimum value), respectively (30 cortical 
structures for the forebrain protocol and 15 cortical structures for the intrinsic protocol 
from at least 10 organoids each). 
(C) Sample images of immunostaining for NPC marker (SOX2) and neuronal marker 
(TUJ1 and CTIP2) in organoids from the forebrain or “intrinsic protocols” at day 28. 
Scale bars: 100 µm. 
(D) Box plot for relative VZ thickness at day 28. Similar to (B) (20 cortical structures 
from at least 10 organoids each).   
(E-F) Effect of BPA on forebrain organoids. Shown are sample images of 
immunostaining for NPC marker (SOX2) and neuron marker (TUJ1) to control and BPA-
treated forebrain organoids (E) and quantification of relative VZ thickness (F) at day 28. 
Organoids were treated with BPA from day 14 to 28. Scale bar: 100 µm. Values 
represent mean ± SEM. (n = 21 cortical structures from at least 10 organoids; ***P < 




3.3.3 - Multiple Progenitor Zones that Recapitulate Human Embryonic Neocortex 
Development  
To characterize developmental progression, we systematically performed 
immunohistochemical analysis of day 28, 56 and 84 organoids. We observed well-
defined VZ-like structure with packed SOX2+ NPCs near the lumen at all three time 
points (Figure 3A-C). At day 28, a layer formed above the VZ containing a mixture of 
TBR2+ IPCs and CTIP2+ neurons, reminiscent of the preplate (PP) in human cortical 
development (Figure 3A). By day 56, distinct SVZ-like structures containing a mixture of 
SOX2+ NPCs, TBR2+ IPCs and immature neurons formed above VZ, and cortical plate-
like (CP) structures containing pure CTIP2+ neurons formed above the VZ and SVZ 
(Figure 3B).  
One hallmark of embryonic human cerebral cortex is the prominence of 
specialized oRGCs in the oSVZ layer (Dehay et al., 2015; Lui et al., 2011). Similar to the 
developing human cortex, in day 84 organoids a thin gap appeared to separate the 
expanded SVZ into an inner SVZ-like (iSVZ) region that contains densely packed TBR2+ 
IPCs and an oSVZ-like region (Figure 3C). Recent studies have identified markers 
preferentially expressed by oRGCs in the developing human cortex, including HOPX, 
FAM107A and PTPRZ1 (Pollen et al., 2015; Thomsen et al., 2015). Using antibody 
reagents that we validated with gestational week 22 (GW22) human tissues, we found a 
large number of SOX2+HOPX+ oRGCs in day 84 organoids (Figure 3D). Previous 
cerebral organoid protocols only generated sparse NPCs with apparent oRGC 
characteristics that did not organize into a progenitor layer outside the VZ (Lancaster et 
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al., 2013). In contrast, our forebrain organoids exhibited a distinct SOX2+HOPX+ oSVZ-
like layer separated from the SOX2+HOPX- VZ layer (Figure 3D). In some cases, we 
observed HOPX+ radially-oriented basal processes from these oRGCs with pial contact 
but lacking an apical process, a morphological hallmark of human oRGCs (Hansen et al., 
2010). Two other oRGCs markers, FAM107A and PTPRZ1, were also expressed in 
oSVZ, indicating that these RGCs are molecularly distinct from VZ NPCs (Figure 3E, 
G). Many SOX2+ progenitors in the oSVZ were positive for cell cycle marker Ki67, 
indicating active cell division in this region (Figure 3F). 
The presence of a prominent oRGC-like population in day 84 forebrain organoids 
offers an opportunity to follow the time-course of oRGC marker expression at different 
stages of organoid development. A recent study showed that oSVZ-exclusive expression 
of HOPX, FAM107A and PTPRZ1 does not occur in the developing human cortex until 
gestational week 15-20 (Pollen et al., 2015). Interestingly, very limited HOPX expression 
was detected in day 28 organoids, while at day 56 its expression was prominent in both 
VZ and SVZ, not exclusive to SVZ.  
Together, these results demonstrate that forebrain organoids exhibit multi-layer 
progenitor zone organization that recapitulates embryonic human cortical development, 
including a prominent oSVZ layer with oRGC-exclusive expression of defined molecular 
markers. Our system provides a new model to investigate the origin, property and 
mechanisms that regulate human oRGCs. 
3.3.4 - Generation of Diverse Neuronal Subtypes of All Six Cortical Layers 
Next, we performed detailed expression analysis of markers for different neuronal 
subtypes in forebrain organoids over the course of development (Figure 3H). At day 28, 
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the neuronal layer contained neurons expressing deep layer cortical neuron markers 
CTIP2 and TBR1, as well as neurons expressing the Cajal-Retzius cell marker REELIN 
(Figure 3I). At day 56 and 70, the SVZ contained neurons weakly expressing CTIP2, a 
feature of migrating immature neurons found in this region (Lui et al., 2011) (Figure 3J-
K). The CP-like structure hosted a dense population of neurons expressing deep layer 
cortical neuron marker CTIP2 and TBR1, as well as a sparser population expressing 
upper layer cortical neuron marker SATB2 that were localized closer to the pial surface 
(Figure 3J-K). There was also a cell-sparse layer visualized by REELIN and DCX 
expression at the pial surface, resembling the marginal zone (MZ) that normally become 
layer I in vivo. At day 84, late-born SATB2+ neurons formed a layer partially separated 
from the early-born CTIP2+ layer, suggesting specification of upper and deep cortical 
layers (Figure 3L). Furthermore, neurons expressing layer II/III neuron markers CUX1 
and BRN2 started to appear with the CUX1+ neuronal layer localized near the pial 
surface (Greig et al., 2013) (Figure 3L). Quantification showed CP and SVZ layer 
expansion and VZ layer reduction from day 56 to 84 (Figure 3M). These features 
resemble the developing human cortex, in which VZ shrinks to 1-2 cell widths across the 
layer by GW22 and the oSVZ become the dominant progenitor zone responsible for 
neurogenesis and CP expansion.  
Together, these results reveal the developmental time course of marker expression 
for neurons of all six cortical layers in forebrain organoids (Figure 3H). Importantly, 
quantitative analysis of different organoids and iPSC lines shows little variability in the 
relative thickness of different layers (Figure 3M), again indicating robustness and 








Figure 3. Organization and Marker Expression of Different Progenitor Zones and Cortical 
Neurons of all Six Layers. 
(A-C) Schematic representations and sample images of forebrain organoids for 
immunostaining of NPC marker SOX2, IPC marker TBR2, and neuron marker CTIP2 at 
Day 28 (A), 56 (B) and 84 (C). Scale bars: 50 µm. PP: preplate; VZ: ventricular zone; 
MZ: marginal zone; CP: cortical plate; SVZ: subventricular zone; oSVZ: outer 
subventricular zone; iSVZ: inner subventricular zone.  
(D-G) Sample images of immunostaining of oRGC markers HOPX (D), FAM107A (E) 
and PTPRZ1 (G), and active cell cycle marker Ki67 (F) in day 84 forebrain organoids. 
Note that oRGC markers are exclusively expressed within the oSVZ-like region and co-
localize with NPC marker SOX2. Scale bars: 50 µm. 
(H) Schematic representation of marker expression for cortical neurons in the mature 
mammalian neocortex.  
(I) Sample images of immunostaining for preplate Cajal-Retzius cell marker REELIN and 
deep layer neuron markers CTIP2 and TBR1 in day 28 forebrain organoids. Scale bar: 
50 µm. 
(J-K) Sample images of immunostaining for deep layer neuron markers (CTIP2 and 
TBR1) and superficial layer neuron marker (SATB2) in forebrain organoids at day 56 (J) 
and 70 (K). Images shown in (K) are from consecutive sections for the same cortical 
structure. Scale bar: 50 µm. 
(L) Sample images of immunostaining for deep layer neuron markers (CTIP2 and TBR1) 
and superficial layer neuron markers (SATB2, BRN2 and CUX1) in forebrain organoids 
at day 84. Images shown are from consecutive sections for the same cortical structure. 
Scale bar: 50 µm. 
(M) Sample image showing layer specification in forebrain organoids and quantification 
of the relative thickness of VZ, SVZ and CP at days 56 and 84 for two iPSC lines. The VZ 
is defined by SOX2+ NPCs densely organized in distinct radial morphology; SVZ is 
defined by the region with mixed populations of SOX2+ NPCs and CTIP2+ migrating 
neurons outside the VZ; CP is defined by the region outside SVZ to the pial surface with 
pure neuronal populations. Relative thickness is the ratio between thickness of VZ, SVZ 
or CP to the total thickness from ventricular to pial surfaces. For each cortical 
structures, three measurements were taken at 45 degree angles to obtain the mean. 




3.3.5 - Molecular Signatures of Forebrain Organoids at Different Developmental Stages 
To further compare our forebrain organoids to in vivo human brain development, 
we performed RNA-seq analyses of global transcriptomes from day 26, 40, 54 and 100 
organoids. We compared organoid transcription profiles to published datasets from 21 
different human fetal organs during the first and second trimester (Roost et al., 2015). 
Pearson’s correlation analysis showed that organoids from all 4 time points strongly 
correlated with fetal brains and spinal cord, with less or no correlation with other fetal 
somatic tissues (Figure 4A). Further comparison with published transcriptomes from 
human dorsolateral prefrontal cortex samples across six stages over the life span (Jaffe et 
al., 2015) showed that organoids at different stages exhibited the highest correlation with 
fetal brain tissues, with the best correlation at day 100. These results suggested that 
organoid development is reminiscent of fetal human brain development at the molecular 
level. 
To pinpoint developmental stages and brain subregion identities of forebrain 
organoids, we performed large-scale comparisons with transcriptome datasets of 16 
different human brain regions at 11 developmental stages from the Allen Brain Atlas. 
Interestingly, transcriptome analyses revealed a temporal correlation between organoid 
development and fetal human brain development, particularly for prefrontal cortex 
development (Figure 4B). For example, day 26-54 organoid profiles were closer to 
several subregions of prefrontal cortex at 8-9 PCW, whereas day 100 organoids were 
more closely related to 17-24 PCW, or even 35 PCW for some subregions (Figure 4B), 
well into the third trimester of human fetal development.  
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We also identified differentially expressed genes during organoid development. 
These genes displayed similar trends during brain development from fetal to later stages 
in vivo (Figure 4C). Gene Ontology analysis revealed enrichment of many neuronal 
function pathways among upregulated genes (Figure 4D) and enrichment of cell cycle-
related pathways among down-regulated genes. Interestingly, common gene analysis 
between differentially expressed genes during organoid development and risk genes for 
schizophrenia or autistic spectrum disorders showed significant overlap (P < 0.001, chi-
square test; Figure 4E). Therefore, the organoid system can be used to study the 
functional impact of the dynamic expression of these disease risk genes in human brain 
development.   
Together, our systematic and comprehensive transcriptome comparisons provide 








Figure 4. Correlation of Global Transcriptomes between Forebrain Organoid and Fetal 
Human Brain Development.  
(A) Heatmap plot of Pearson’s correlation analysis of RNA-seq datasets from forebrain 
organoids at days 26, 40, 54 and 100 and published datasets from 21 different human 
fetal organs during the first and second trimester of development (Roost et al., 2015). 
Shown are averaged values for biological replicates.  
(B) Heatmap plots of Pearson’s correlation analysis of RNA-seq datasets among 
forebrain organoids at different stages and published transcriptome datasets of 3 
different cortical subregions at 10 fetal developmental stages and 1 postnatal stage from 
Allen Brain Atlas (http://www.brain-map.org/).  
(C) Heatmap plot of gene expression dynamics from up-regulated genes between D26 
and late stages of organoid development.  
(D) Gene Ontology analysis of upregulated genes by The Database for Annotation, 
Visualization and Integrated Discovery (DAVID) (Huang da et al., 2009). Nine top terms 
(in terms of p-values) are shown.  
(E) Overlap of differentially expressed genes during organoid development with known 
schizophrenia related risk genes (from Schizophrenia Gene Resource: 
(http://bioinfo.mc.vanderbilt.edu/SZGR/) and autism related risk genes (from Simons 
Foundation Autism Research Initiative: https://gene.sfari.org/autdb/HG_Home.do). 




3.3.6 - Functionally Connected Cortical Neurons and GABAergic Neuronal Subtypes 
To assess physiological properties of cells in organoids, we performed 
electrophysiological whole-cell recording in slices acutely sectioned from organoids. 
Recorded neurons were capable of firing trains of TTX-sensitive action potentials in 
response to current injection (Figure 5A). Neurons showed rectifying membrane 
properties, Na+ currents, and K+ currents in response to voltage ramps. Cells with linear 
membrane properties were also observed, indicating the presence of astrocytes (Figure 
5B). We observed developmental changes of intrinsic properties in recorded neurons 
across different stages. Both Na+ and K+ channel currents increased over time, which was 
accompanied by a decrease in membrane resistance and an increase in membrane 
capacitance.  
To visualize morphology of individual neurons, we electroporated organoids to 
sparsely label cells with GFP. At day 85, GFP+ neuron exhibited complex neuronal 
morphology with spine-like structures in close association with SV2+ puncta (Figure 5C). 
About 50% of cells recorded showed spontaneous excitatory postsynaptic current 
(sEPSC) that were sensitive to the glutamate receptor antagonist DNQX (Figure 5D). 
Both intrinsic properties and synaptic connectivity were similar between two iPSC 
clones.  
One hallmark of neuronal maturation is the switch of cellular responses to GABA 
from depolarization to hyperpolarization (Owens and Kriegstein, 2002). This shift is due 
to developmentally regulated changes in intracellular Cl- concentration, mediated by 
down-regulation of chloride-importing sodium-potassium-chloride co-transporter 1 
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(NKCC1) and up-regulation of chloride-exporting potassium-chloride cotransporter 2 
(KCC2) (Ben-Ari and Spitzer, 2004). To assess whether human neurons in organoids 
recapitulate this switch, we performed immunohistochemistry and found that NKCC1 
was expressed at both days 56 and 84, whereas KCC2 was strongly expressed in the CP 
at day 84 but not day 56. We further performed a functional assay to monitor Ca2+ rise in 
response to GABA-induced depolarization (Ganguly et al., 2001) (Figure 5E). 
Quantification showed an increase in the percentage of neurons without GABA-induced 
Ca2+ rise among all neurons that responded to glutamate over time (Figure 5F). 
Therefore, forebrain organoids exhibit functional features of neuronal maturation found 
in vivo. 
Similar to our 2D differentiation protocol to direct human iPSCs towards a 
forebrain fate, which results in about 10% GABAergic neurons (Wen et al., 2014), we 
observed GABA+VGLUT- neurons in forebrain organoids after day 84 (Figure 5G). 
Electrophysiological recordings in the presence of DNQX to block all glutamatergic 
synaptic transmission also showed spontaneous postsynaptic currents with slower 
kinetics (Figure 5H). Immunohistological analysis further revealed the presence of at 
least three major subtypes of GABAergic neurons expressing parvalbumin, nNOS or 
somatostatin (Figure 5I). Consistent with electrophysiological recording results (Figure 
5B), we observed S100+ and GFAP+ astrocytes in close association with surrounding 
neurons (Figure 5J-L). Together, these findings demonstrate that forebrain organoids 









Figure 5. Functional Characterization of Forebrain Organoids. 
(A-D) Electrophysiological and morphological analyses of cells in forebrain organoids. 
Shown in (A) are sample current-clamp traces of a neuron firing a train of action 
potentials in response to 10 pA of current injection. A hyperpolarizing step of -5 pA is 
also shown. Shown in (B) are sample voltage-clamp traces showing currents in response 
to a ramp protocol (- 90 mV to 110 mV). Shown in (C) is a sample image of a neuron in a 
day 85 forebrain organoid labeled by GFP upon electroporation. The insert shows 
surface rendering of a dendritic spine structure on a GFP-labeled neuron with the pre-
synaptic terminal labeled by SV2 staining in red. Scale bars: 50 µm. Shown in (D, left) 
are sample recording traces of sEPSCs and pharmacological blockade by the glutamate 
receptor antagonist DNQX. Identified sEPSC events are overlaid and the average sEPSC 
trace is shown. Also shown in (D, right) is the summary of the percentage of cells that 
exhibited detectable sEPSC events in organoids of different ages.  
(E) Calcium imaging analysis of cellular response to GABA application (10 M). Day 
100 organoids were loaded with Fluo-4. Shown in left panels are sample heat maps of 
GABA-induced fluorescence changes (ΔF/F) within the same region in the absence or 
presence of Bicuculline (Bicu. 50 M). The color scale at the right indicates a ΔF/F 
range of 0 to 250%. Scale bars: 50 µm. Shown in the middle panel are calcium response 
curves for individual cells indicated in the heatmap. Shown in the right panel is the 
summary of ΔF/F in response to GABA in absence or presence of bicuculline. Values 
represent mean ± SEM (n = 43 neurons from 3 organoids). 
(F) Developmental shift of the percentage of cells in forebrain organoids that exhibit 
calcium rise in response to GABA (10 M) and glutamate (20 M). Shown is the 
summary of percentages of cells without GABA-induced Ca2+ rise (GABA-) among those 
that responded to glutamate (Glu+). Value represent mean (n = 26, 77 and 69 neurons 
from 3 organoids at days 50, 80 and 100, respectively). 
(G-I) GABAergic neurons in forebrain organoids. Shown are sample images of 
immunostaining for GABA and VGLUT1 (G) and GABAergic neuron subtypes (I), 
including parvalbumin (PV)-, neuronal nitric oxide synthases (nNOS)- and somatostatin 
(SST)-expressing neurons. Note that GABA+ neurons did not express the glutamatergic 
neuron marker VGLUT1 (G). Shown in (H) are sample recording traces of sIPSCs. 
Identified sIPSC events are overlaid and the average sIPSC trace is shown. Scale bars: 
50 µm.  
(J-L) Astrocytes in forebrain organoids after day 100. Shown are sample images of 
immunostaining for astrocyte markers S100β (J) and GFAP (L). Astrocytes were 
distributed among SATB2+ cortical neurons and display complex morphologies. Scale 




3.3.7 - Generation of Midbrain and Hypothalamic Organoids from Human iPSCs 
As one application of Spin is to test various culture conditions, we explored 
approaches to generate organoids with other brain region identities. Building upon a 
previously established 2D differentiation protocol for generating midbrain dopaminergic 
(DA) neurons (Kriks et al., 2011), we applied Sonic Hedgehog (SHH) agonists 
(recombinant SHH and Purmorphamine), Fibroblast growth factor 8 (FGF-8), SMAD 
inhibitors (SB431542 and LDN193189), and GSK3 inhibitor (CHIR99021) to induce 
floor plate differentiation of human iPSCs, which were then transferred to SpinΩ at day 
14 (Figure 6A). At day 18, midbrain organoids showed organized neuroepithelial 
structures expressing NESTIN and floorplate precursor marker FOXA2, but not DA 
neuron marker TH, whereas very few cells expressed forebrain marker PAX6 or 
hypothalamus progenitor marker RAX1 (Figure 6B and S6A). At day 38, we observed 
numerous TH+ DA neurons in midbrain organoids (Figure 6C). At day 56, the majority of 
TH+ neurons expressed FOXA2+ and dopamine transporter (DAT). In addition, midbrain 
organoids contained TH+ cells that expressed midbrain DA neuron markers NURR1 and 
PITX3. At day 75, PITX3 was robustly expressed by TH+ cells, suggesting specification 
of A9 DA neurons (Chung et al., 2005) (Figure 6D). To quantify TH and FOXA2 
expression, we dissociated midbrain organoids at day 65 to plate on Matrigel-coated 
tissue culture plates for 5 days. Immunohistochemistry analysis showed that 95 + 1% of 
cells were FOXA2+ and 55 + 4% were TH+ DA neurons (n = 6; Figure 6E).  
We also explored methods to generate hypothalamic organoids from human 
iPSCs. We initially tested a number of published protocols (Wang et al., 2015; Wataya et 
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al., 2008) using our Spin system, but differentiation was not robust and most organoids 
died after 30 days (data not shown). To increase efficiency and to adapt cells to Spin, 
we first treated human iPSCs with dual SMAD inhibitors (SB431542 and LDN193189) 
to pre-pattern them to the neuroectodermal fate (Chambers et al., 2009) (Figure 6F). After 
3 days, embryonic bodies were treated with Wnt3A, recombinant SHH and 
Purmorphamine to be further patterned into the hypothalamic lineage (Dale et al., 1997; 
Lee et al., 2006; Shimogori et al., 2010). At day 8, the majority of cells in organoids 
expressed NKX2.1, NKX2.2, RAX1, SOX2, NESTIN and FOXA2, markers that are 
consistently expressed during early hypothalamus development (Blackshaw et al., 2010; 
Byerly and Blackshaw, 2009; Lu et al., 2013) (Figure 6G). At day 40, peptidergic 
neuronal markers, including POMC, VIP, OXT and NPY (Merkle et al., 2015), were 
detected in organoids generated from different iPSC lines (Figure 6H). Furthermore, a 
subset of cell populations within the organoids expressed OTP, a homeobox protein 
essential for specification of hypothalamic neuronal lineages (Wang and Lufkin, 2000) at 
day 40, but not day 8 (Figure 6H). Together, these findings demonstrate the versatility of 








Figure 6. Generation of Midbrain and Hypothalamic Organoids using SpinΩ Bioreactor.  
(A-E) Midbrain organoids from human iPSCs. Shown in (A) is a schematic diagram of 
the protocol for generating midbrain organoids. See Experimental Procedures for detail. 
LDN: LDN193189 (100 nM); SHH: recombinant human Sonic Hedgehog (100 ng/ml); 
Pur: purmorphamine (2 M); FGF-8: Fibroblast Growth Factor 8 (100 ng/ml). Shown in 
(B, top panels) are sample images of day 18 organoids showing expression of the floor 
plate precursor marker (FOXA2), but not the dopaminergic (DA) neuron marker TH 
(Tyrosine hydroxylase), forebrain progenitor marker (Pax6), or hindbrain progenitor 
marker (Rax1). Scale bars: 100 µm. Also shown in (B, bottom panel) is a summary of 
marker expression. Values represent mean ± SEM (n = 4 organoids each; *P < 0.05, 
Student’s t-test). Also shown are sample images of immunostaining of midbrain 
organoids at day 38 (C) and day 75 (D) for FOXA2, TH and midbrain DA neuron maker 
Pituitary homeobox 3 (PITX3). Shown in (E) are sample images of immunostaining of 
monolayer cultures at 5 days after dissociation and plating of day 65 midbrain 
organoids. Scale bars: 50 µm.  
(F-H) Hypothalamic organoids. Shown in (F) is a schematic diagram of the protocol for 
generating hypothalamus organoids. See Experimental Procedures for details. WNT: 
recombinant Wnt3a (10 ng/ml); CNTF: Ciliary neurotrophic factor (10 ng/ml); FGF-2: 
Fibroblast Growth Factor 2 (10 ng/ml). Shown in (G) are sample images of day 8 
organoids. Shown in (H) are sample images of day 40 organoids for peptidergic neuronal 
markers. Scale bars: 100 µm. Also shown in (H) is a summary of quantification for 
peptidergic neuronal markers expression in day 40 hypothalamus organoids from 2 iPSC 




4.4 - Discussion 
We have developed a cost effective, simple to use system for 3D organoid 
cultures using a miniaturized multi-well spinning bioreactor, SpinΩ. The low cost of the 
platform, 50-fold less per condition than a standard spinning flask, allowed us to optimize 
protocols to generate reproducible forebrain organoids with minimized heterogeneity and 
variability that are amendable to quantitative analyses, and better recapitulates 
developing human cortex in layer formation, progenitor zone organization, and gene 
expression. Specifically, forebrain organoids exhibit well-developed oSVZ-like region 
containing NPCs that share molecular and morphological features of human oRGCs, 
organized neuronal subtypes of all six cortical layers and GABAergic neuronal subtypes. 
We further demonstrated the versatility of the SpinΩ system by developing protocols to 
generate organoids recapitulating characteristics of other brain regions. Finally, we 
applied our forebrain organoid platform for chemical compound testing and modeling 
ZIKV infection.  
4.4.1 - SpinΩ, a Miniaturized Spinning Bioreactor for Cost-effective Organoid Culturing  
Several pioneering studies showed that cerebral organoid systems offer improved 
growth condition for 3D tissue, leading to a more representative model of the developing 
human brain than had been achieved with traditional methods (Danjo et al., 2011; 
Kadoshima et al., 2013a; Lancaster et al., 2013; Mariani et al., 2015; Pasca et al., 2015). 
In particular, use of a spinning flask provides a 3D low-shear stress suspension culture 
with enhanced diffusion of oxygen and nutrients and supports formation of larger, 
 
45 
continuous cortical structures (Lancaster et al., 2013). At least under our culture 
conditions, our direct comparison with stationary and orbital shaker cultures confirmed 
the beneficial effect of spinning for forebrain organoids. However, maintaining organoids 
in standard spin flasks is very expensive due to large volumes of culture media, making it 
cost-prohibitive to supplement the media with small molecules and growth factors to 
promote growth and differentiation of organoids. Our miniaturized spinning bioreactor 
SpinΩ addresses this limitation by dramatically reducing the required media volume, 
which allows for systematic and efficient testing of culture conditions in parallel. 
Moreover, SpinΩ’s small footprint and compact shape reduces the incubator space 
required, a feature that is further highlighted by the stackable version. Importantly, many 
of the design parameters of SpinΩ, including number and size of wells, rotation speed, 
shaft angle and shape, can be customized based on specific needs. Together, the SpinΩ 
system provides better accessibility and higher efficiency for developing 3D tissue 
cultures for applications related to the brain and other organs. 
4.4.2 - Advanced Features of Forebrain Organoids and Areas for Future Improvements    
Compared to several pioneering cerebral organoid systems, our forebrain 
organoids show high reproducibility, which is critical to realize its promises as a 
standardized in vitro model for human cortical development. Two rounds of patterning 
factors effectively induce forebrain differentiation and significantly reduces brain region 
heterogeneity. It further reduces temporal heterogeneity of neural differentiation within 
forebrain organoids, allowing systematic characterization of a developmental time-
course. Our proof-of-principle study with BPA demonstrates that many parameters in 
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these organoids can be reliably quantified, therefore this platform can be used for drug 
testing, compound screening and disease modeling.   
Importantly, forebrain organoids better recapitulates developing human cortex 
among multiple dimensions compared to previously reported methods. First, it produces a 
well-defined oSVZ-like progenitor region that is separated from the iSVZ-like region and 
contains a prominent oRGC-like NPC layer (Figure 3C-D), all of which are distinct 
features of developing human cortex that are absent in rodents and previous organoid 
models. The time-course of SVZ and oSVZ layer formation and progression also displays 
similarities with dynamic changes during human cortical development in vivo. Moreover, 
oRGCs in forebrain organoids express all three recently identified markers preferentially 
expressed by human oRGCs in vivo (Figure 3D, E, G). Second, forebrain organoids 
robustly generate organized cortical neurons expressing markers found in all six layers of 
human neocortex, including for the first time a layer of CUX1+ neurons destined for layer 
II (Figure 3L). Interestingly, the production peak of late-born neurons expressing the 
upper layer neuron marker SATB2 took place after day 56, coinciding with the 
specification and expansion of oSVZ. Because the height of oSVZ proliferation coincides 
in time with formation of upper cortical layers, which are particularly cell dense in 
human cortex, it has been suggested that the abundant oRGC population in human oSVZ 
is responsible for this evolutionary change (Lui et al., 2011; Marin-Padilla, 1992). In 
addition, plated human oRGCs after dissociation from post-mortem tissue was shown to 
preferentially give rise to upper layer neurons over deep layer neurons (Pollen et al., 
2015). Therefore, the presence of well-developed oSVZ may be responsible for robust 
generation of upper layer neurons in forebrain organoids. Our electrophysiology and 
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calcium imaging analyses revealed functional neuronal properties, active synaptic 
transmission and recapitulation of neuronal maturation characteristics similar to those 
observed in vivo, including a switch in GABA response properties. While a previous 
study has shown the presence of GABAergic neurons in organoids (Mariani et al., 2015), 
we show, for the first time, presence of GABAergic neuronal subtypes in organoids. The 
apparent absence of NKX2.1+ ventral progenitors during early differentiation suggest a 
possible dorsal origin of GABAergic neurons, a distinct feature of primates and humans 
(Jakovcevski et al., 2011; Petanjek et al., 2009; Yu and Zecevic, 2011). Lastly, large-
scale comparison of global transcriptome analyses confirms that development of 
forebrain organoids closely correlates with human cortical development at the molecular 
level. Forebrain organoids with a well-developed oSVZ will significantly expand our 
ability to study distinct characteristics of human cortical development that cannot be 
represented in rodent models. Compared to studies on postmortem human tissues, 
forebrain organoids offer a model to investigate embryonic human cortical development 
as a continuous dynamic process in live cells, and allows pharmacological and genetic 
manipulations to investigate underlying mechanisms. 
It is likely that continuous optimization can further improve the forebrain 
organoid system. First, depletion of nutrients and oxygen in the interior of organoids is 
one factor limiting our ability to model human brain development beyond the second 
trimester. Due to the dramatic expansion of the cortical plate, progenitor zones in 
forebrain organoids become gradually depleted after day 100. One potential solution may 
come from recently reported advances in engineering vascularized 3D tissue by 
endothelial cell co-cultures (Takebe et al., 2013; Takebe et al., 2014) or implementing 
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microfluidic perfusion networks as has been proposed (Yin et al., 2016). An alternative 
approach would be to explore culture conditions that can accelerate the development of 
forebrain organoids, and produce features of late-stage cortical development with smaller 
overall tissue size. Second, our forebrain organoids do not contain well-defined regions 
representing the intermediate zone (IZ) and subplate, which play important roles in 
neuronal migration during cortical development (Bystron et al., 2008a). Intriguingly, a 
previously reported cortical neuroepithelial system showed formation of a cell-sparse IZ-
like region despite lacking oSVZ (Kadoshima et al., 2013a). Third, although we have 
identified cortical neurons expressing markers found in all six layers of human cortex, 
they display only rudimentary separation and are not as six distinctly layers. Additional 
chemical and physical cues may be required to better regulate neuron migration and more 
precise localization of upper layer neurons above existing post-migratory neuron layers. 
4.4.3 - Additional Future Applications 
In addition to modeling brain disorders due to environmental insults or genetic 
causes using iPSCs derived from patients and healthy subjects, the organoid system 
provides a novel and renewable source of human neurons and other cell types, such as 
DA neurons for transplantation in models of Parkinson’s disease. Organoid growth is 
coupled with dramatic expansion in cell numbers. For example, embryoid bodies of 
around 300 μm in diameter could expand to organoids that are up to 3 mm in diameter, 
achieving a 1000-fold expansion in cell mass. Finally, just as the cerebral organoid 
methodology was inspired by self-organizing tissue organoids developed for other 
organs, SpinΩ has the potential to be broadly applied to other types of 3D tissue cultures 
beyond the nervous system, where SpinΩ’s advantages in reduced cost, increased 
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throughput, enhanced cell survival and improved factor absorption would prove 
beneficial. The modular stackable version of SpinΩ allows for consistent culture 
conditions for numerous plates simultaneously and new possibilities for large-scale 3D 




4 - Using forebrain organoids to investigate Zika virus-induced birth defects.  
(This chapter was published(Qian et al., 2016). I am the first author and was involved in 
all aspects of the study.) 
4.1 - Introduction 
ZIKV, a mosquito-borne flavivirus, has been reportedly spread in over 70 
countries and territories globally (CDC, 2016; Heukelbach et al., 2016). While ZIKV 
infection in adults usually results in mild symptoms, there has been tremendous attention 
drawn towards the co-occurrence of ZIKV outbreaks and an increased incidence of 
newborns with microcephaly, a condition where infants are born with an abnormally 
small head. Since the declaration of ZIKV as a global health emergency by the World 
Health Organization (WHO), growing evidence from clinical examinations of 
microcephalic fetal tissues has shown the presence of ZIKV in damaged fetal brains 
(Heymann et al., 2016; Mlakar et al., 2016a; Ventura et al., 2016). More recently, the 
United States Centers for Disease Control and Prevention (CDC) evaluated existing 
evidence and concluded that ZIKV causes microcephaly and other severe fetal brain 
defects (CDC, 2016). Live infected fetal tissues are not accessible and postmortem tissues 
are variable in their quality and genetic backgrounds, and clinical studies alone cannot 
provide sufficient insights for understanding how ZIKV causes this damage. Therefore, 
researchers have adopted brain organoid models to study ZIKV’s cellular tropism and 
molecular mechanisms in controlled settings.  
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Brain organoids arise from the self-assembly capability of human pluripotent stem 
cells and is believed to be largely guided by the same intrinsic mechanism responsible for 
fetal development in vivo (Lancaster and Knoblich, 2014c). As a result, while monolayer 
and neurospheres usually contains relatively pure populations of one or a few cell types, 
brain organoids better recapitulate the composition, diversity and organization of cell 
types found in the developing human brain. By exposing the whole organoid to ZIKV, we 
could analyze and compare the efficiency with which ZIKV infects different cell types 
and different cell layers/regions within the same organoids. In addition, comparing to 2D 
differentiation protocols, brain organoids of different stages can more accurately mimic 
the developing trajectory of fetal brain within the first and second trimesters of 
pregnancy. Because these tempo-spatial transitions take place as a continuous process, 
researchers can examine the organoids at any time points of interest to gain insight on 
both short- and long-term effects of viral infection over the course of fetal brain 
development. Therefore, under the context of a global health emergency, such as the 
ZIKV outbreak, the brain organoid systems can provide direct insight into human neural 




4.2 - Methods 
ZIKV was prepared and titered as previously described (Tang et al., 2016). 
Supernatant from infected mosquito cells was thawed, diluted 1:40 (0.25x) or 1:10 (1x) 
into forebrain organoid differentiation media, and applied directly on forebrain organoids 
maintained in SpinΩ. The virus inoculum was removed after a 24-hour incubation in 
spinning culture and replaced with fresh medium. Forebrain organoids infected at day 28 
were pulsed with 10 μM EdU for 2 hours on day 42, and fixed for analysis 24 hours later. 
Quantitative analyses were conducted on randomly picked cortical structures captured by 
confocal microscope (Zeiss LSM 700). Cell proliferation was measured by density of 
PH3+ or EdU+ nuclei in ventricular structures similar to those described in BPA 
experiments. Cell death was quantified by counting cleaved caspase-3+ nuclei over total 
nuclei stained by DAPI. Area of VZ and lumen, and thickness of VZ and neuronal layers 
were measured using ImageJ software. Overall size of organoids was measured under 




4.3 – Results 
4.3.1 - Modeling ZIKV Infection during Different Stages of Cortical Development  
We performed a series of experiments to model ZIKV infection at different stages 
of human cortical development via exposure of forebrain organoids to ZIKV in culture 
medium for 24 hours in Spin. Consistent with findings from our recent 2D study (Tang 
et al., 2016), ZIKV readily infected NPCs in day 14 forebrain organoids (Figure 7A and 
8A). After 18 days, ZIKV infection resulted in an overall decrease in organoid size 
(Figure 8B-C). Quantitative analyses showed dramatically reduced thickness and size of 
ventricular structures (Figure 8D-F), likely due to significant cell death and suppression 
of NPC proliferation (Figure 7B-C). We also observed a significant increase in the size of 
lumen within ventricular structures (Figure 8F), reminiscent of dilated ventricle size in a 
recently reported case of a fetal brain infected with ZIKV (Driggers et al., 2016).   
Next, we used two different doses of ZIKV to treat day 28 organoids, which 
contained both progenitor and neuronal layers (Figure 8G). Interestingly, ZIKV 
preferentially infected SOX2+ NPCs, and infected much fewer TBR2+ IPCs or CTIP2+ 
immature neurons when examined 4 days later (Figure 7D), suggesting specific tropism 
of ZIKV towards NPCs in the 3D tissue. By day 14, we observed a significantly 
increased number of ZIKV infected cells (Figure 8H), consistent with productive 
infection by ZIKV in NPCs (Tang et al., 2016). In addition to the significant reduction in 
overall size (Figure 8I), we also observed a ZIKV-dose-dependent reduction in both VZ 
and neuronal layer thickness (Figure 7E), decrease of EdU+ proliferating cells, and 
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increase of activated caspase 3+ cells (Figure 7F and 8J). Interestingly, a significant 
proportion of activated caspase 3+ cells are neurons negative for ZIKVE, indicating non-
autonomous toxicity effects. Therefore, ZIKV infection of early stage organoids, which 
corresponds to first trimester of human fetal development, leads to features resembling 
microcephaly.    
 We also assessed the effect of ZIKV on day 80 forebrain organoids 
(Figure 8J). After 10 days, we observed again preferential localization of ZIKV in SOX2+ 
NPCs in VZ and oSVZ, but also in CTIP2+ neurons and occasionally in GFAP+ 
astrocytes (Figure 7G-H). The infection appeared less robust compared to earlier stages 
of organoids, possibly due to the limited penetration of ZIKV from the culture medium to 
the interior of organoids where NPCs reside. After 20 days, we observed significantly 
increased number of infected cells (Figure 7I). Despite dramatically expanded neuronal 
population and depletion of the NPC population at this time, quantification again showed 
significantly more SOX+ NPCs with ZIKV than CTIP2+ neurons (Figure 7I). Importantly, 
we observed ZIKV+SOX2+HOPX+ cells, suggesting infection of oRGCs by ZIKV 
(Figure 7J).  
Together, our forebrain organoid system allowed quantitatively investigation of 
impacts of ZIKV infection at different stages of human cortical development and our 
results suggest that ZIKV, once it gain access to the fetal brain, causes microcephalic-like 










Figure 7. Modeling Impact of ZIKV Exposure using Forebrain Organoids. 
(A) Sample immunostaining images of forebrain organoid infected by 1X ZIKV at day 14 
and analyzed at day 24 (14+10). Note localization of ZIKV envelop protein (ZIKVE) in 
VZ and co-localization with the NPC marker SOX2. Scale bar: 100 µm.  
(B-C) Sample immunostaining images of forebrain organoids infected or mock-treated at 
day 14 and analyzed at day 32 (14+18) for the apoptosis marker activated Caspase-3 
(CAS3; B), cell proliferation marker PH3 (C). Scale bars: 100 µm. Also shown are 
quantifications for the percentage of cells positive for CAS3 among the total number of 
nuclei stained by DAPI (B) and density of PH3+ cells within the VZ. Values represent 
mean ± SEM (n = 5 organoids; *** P < 0.0005, Student’s t-test) 
(D) Sample immunostaining image of a forebrain organoid infected by 1X ZIKV at day 
28 and analyzed at day 32 (28+4) for ZIKVE, SOX2+, CTIP2+ or TBR2 (top two panels; 
Scale bars: 100 µm). Also shown are quantifications for the percentages of SOX2+, 
CTIP2+ or TBR2+ cells among the total number of ZIKVE+ cells. Values represent mean 
± SEM (n = 5 cortical structures from 3 organoids; *** P < 0.0005, Student’s t-test).  
(E-F) Forebrain organoids infected with ZIKV (at 1X or 0.25X) or mock-treated at day 
28 and analyzed at day 42 (28+14). Shown in (E) are same immunostaining images and 
quantifications revealing reduced thickness of both VZ (SOX2+ cell layer) and the 
neuronal layer (Tuj1+ CTIP2+) in forebrain organoids infected by 0.25X and 1X ZIKV. 
Shown in (F) are sample immunostaining images and quantification revealing reduced 
cell proliferation labelled by EdU and increased cell death in ZIKV-infected regions. 
Scale bars: 100 µm. Values represent mean ± SEM (n = 5 cortical structures from 3 
organoids; **P < 0.005, ***P < 0.0005, Student’s t-test). 
(G-J) Sample immunostaining images (top) and magnified views (bottom) of forebrain 
organoid infected by 1X ZIKV at day 80 and analyzed at day 90 (80+10; G-H) or day 
100 (80+20; I-J), showing localization of ZIKVE in VZ and oSVZ regions (G, I) and in 
GFAP+ astrocytes (H). Arrows in (J) point to ZIKV+HOPX+SOX2+ oRGC-like cells in the 
oSVZ region. Scale bars: 100 µm. Also shown in (I) are quantifications for the 
percentage of ZIKV+ cells among the total number of SOX2+ or CTIP2+ cells in the 
whole cortical structures. Values represent mean ± SEM (n = 7 cortical structures from 5 








Figure 8. Experimental Paradigms and Additional Characterization for Effects of ZIKV 
Infection on Forebrain Organoids. 
(A-F) Forebrain organoids with ZIKV or mock infection (1X) at day 14 and analyzed at 
day 32 (14+18). Shown in (A) is a schematic diagram for the experimental paradigm. 
Shown in (B-C) are bright field microscopic images (B) and quantification of organoid 
size (C). Scale bar: 1 mm. Also shown are quantifications of VZ area (D), VZ thickness 
(E) and lumen size (F) measured on immunostaining images of mock and ZIKV infected 
organoids. Values represent mean ± SEM (n = 5 organoids; ***P < 0.0005, Student’s t-
test) 
(G-I) Forebrain organoids with mock or ZIKV infection (0.25X or 1X) at day 28 and 
analyzed at day 32 (28+4) or day 42 (28+14). Shown in (G) is a schematic diagram for 
experimental paradigm. Shown in (H) is a summary of the percentage of ZIKVE+ cells 
over DAPI in cortical structures at day 32 and 42. Shown in (I) are bright field 
microscopic images and quantification of organoid size. Scale bar: 1 mm. Values 
represent mean ± SEM (n = 6 organoids; ***P < 0.0005Student’s t-test).  
(J) Sample immunostaining images of 42 (28+14) day forebrain organoids with mock or 
ZIKV (1X) infection showing cell apoptosis marked by CAS3. 





4.4 - Discussion 
As an application of our organoid platform for disease modeling, we modeled the 
impact of ZIKV exposure at different stages of pregnancy. Recent clinical studies have 
established that ZIKV can pass through placenta to gain access to the developing fetal 
brain (Calvet et al., 2016; Driggers et al., 2016; Mlakar et al., 2016b). We show that 
among different cell types in the 3D tissue, ZIKV exhibits specific tropism towards 
NPCs, including oRGCs, although ZIKV could be detected in immature neurons, IPCs 
and astrocytes (Figure 7D, G-I). Time course analysis further shows that ZIKV infection 
in NPCs is productive, resulting in more infected cells over time. Therefore, even a very 
low dose of ZIKV exposure in vivo may lead to increasingly serious effect with time. 
Consistent with clinical findings that first trimester infections are the most dangerous 
(Cauchemez et al., 2016; Faria et al., 2016), incubating early stage forebrain organoids 
with ZIKV for one day leads to detrimental effects over the course of two weeks, 
mimicking many features of microcephaly, including decreased neuronal layer thickness 
and overall size as well as enlarged lumen/ventricles (Figure 7E and 8I). Mechanistically, 
we show increased cell death and an almost complete suppression of proliferation of 
infected NPCs (Figure 7F). The same ZIKV treatment of day 80 organoids, which is 
more complex and resembles the second trimester based on gene expression comparisons 
(Figure 5B), also leads to preferential infection of SOX2+ NPCs, including HOPX+ 
oRGCs (Figure 7I-J). Together, our results provide compelling evidence that, upon 
exposure to the fetal brain, productive and preferential infection of NPCs by ZIKV leads 
to characteristic features resembling microcephaly. Forebrain organoids therefore provide 
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a quantitative experimental platform for future studies to investigate impacts of different 
ZIKV strains, identify cellular and molecular mechanisms, and screen for therapeutic 
interventions, issues that are critical to resolving the current global health emergency 




5 - Sliced neocortical organoids for modeling distinct cortical neuronal layer formation. 
(This chapter is under revision at Cell Stem Cell as of 12/04/2019. I am the first author 
and was involved in all aspects of the study.) 
5.1 - Introduction 
Brain organoids are human pluripotent stem cell (hPSC)-derived self-organizing 
three-dimensional (3D) tissues with cell types and cytoarchitectural features resembling 
the embryonic human brain (Lancaster and Knoblich, 2014c; Pasca, 2018; Shi et al., 
2017). Recent developments in cerebral cortex organoid technologies have demonstrated 
striking recapitulation of human cortical development during early-to-mid gestation 
periods at molecular, cellular, and structural levels (Amiri et al., 2018; Bershteyn et al., 
2017; Birey et al., 2017; Cugola et al., 2016; Lancaster et al., 2013; Mariani et al., 2015; 
Qian et al., 2016; Qian et al., 2019; Quadrato et al., 2017). However, due to a lack of 
functional circulation systems, the viability of cells within large cortical organoids is 
restricted by the limited supply of oxygen and nutrients delivered via surface diffusion 
(Kadoshima et al., 2013b; Kelava and Lancaster, 2016; Lancaster et al., 2017; Qian et al., 
2016). Brain organoids grown as spheres in 3D suspension culture can expand up to 3 - 4 
mm in diameter, but the cells in the interior suffer hypoxia, and a necrotic core forms 
inside. Despite methods to alleviate the diffusion limit and improve oxygen delivery, 
including using spinning bioreactors or gas-permeable culture plates, supplying higher 
oxygen in the incubator, or cutting organoids into smaller pieces, the healthy area of brain 
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organoids is typically limited to a 300 to 400 μm deep ring along the outer surface 
(Kadoshima et al., 2013b; Qian et al., 2016; Sakaguchi et al., 2015; Watanabe et al., 
2017). This diffusion barrier is particularly detrimental for cortical organoids because 
proliferating progenitor zones are organized in the interior, where they lose access to the 
external culture environment and eventually deplete as the outer layers thicken. The 
depletion of neural progenitor cells (NPCs) prohibits continuous cell generation and leads 
to architectural disorganization, limiting the structural development of organoids (Amiri 
et al., 2018; Qian et al., 2016). In contrast, the developing human embryonic neocortex 
continues to generate neurons and glia in the third trimester to expand the cortical volume 
(Bystron et al., 2008b; Fjell et al., 2015; Malik et al., 2013; Rakic, 2009; Samuelsen et 
al., 2003).  
The increase in cortical plate (CP) thickness during human corticogenesis is 
accompanied by the establishment of six specialized cortical layers, a hallmark of human 
neocortex, which become distinctly separated by cytoarchitecture and layer-dependent 
expression of neuronal subtype markers by the perinatal period (Saito et al., 2011). 
During the mid-gestation stage, however, the upper (Layer II-IV) and deep (Layer V-VI) 
cortical layers are indistinguishable because the majority of CP neurons co-express 
markers for both upper and deep layers and the distribution of layer-dependent neuronal 
markers intermingles extensively (Fame et al., 2011; Ip et al., 2011; Nowakowski et al., 
2017; Ozair et al., 2018; Zhong et al., 2018). A lack of accessibility to normal human 
embryonic tissues from the late gestation period has prevented systematic examination of 
this transition towards establishing separated cortical layers. Moreover, this prolonged 
period of co-expression of markers of different layers and neuronal subtypes is absent 
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during rodent cortical development (Alsio et al., 2013; Britanova et al., 2008; Saurat et 
al., 2013), indicating the presence of human/primate-specific mechanisms controlling 
cortical neuron fate specification post-mitotically.  
Brain organoids have demonstrated tremendous promise in recapitulating human-
specific developmental features, most notably exemplified by the generation of an outer 
subventricular zone (oSVZ)-like progenitor layer containing outer radial glia (oRG)-like 
cells (Bershteyn et al., 2017; Qian et al., 2016). However, the interior hypoxia and cell 
death cause shrinkage of the oSVZ neurogenic niche and disruption of radial glia 
scaffolds in prolonged cultures, prohibiting neuronal production and proper inside-out 
migration required for the formation of cortical lamination (Qian et al., 2019). Thus far, 
despite occasionally observed rudimentary separation, no published cortical organoid 
models have shown consistent formation of CP structures that exhibit distinct separation 
between the upper and deep cortical layers. Here, we report the development of cortical 
organoids that overcome the diffusion limit using a slicing method, which leads to the 
formation of well-separated upper and deep cortical layers. We further demonstrate the 
utility of our system for investigation of molecular mechanisms regulating cortical 




5.2 - Methods 
5.2.1 - Generation of sliced neocortical organoids 
Forebrain organoid at Day 45 were collected from SpinΩ bioreactor using a cut 
P1000 pipette tip and immersed in melted 3% low melting point agarose dissolved in 
DMEM:F12 kept at 37 °C in a custom cubic mold of 1.5 cm sides. Typically, up to 10 
organoids were embedded in one agarose block. Before the agarose solidify, multiple 
organoids were spread evenly and arranged in the same horizontal plane, with minimal 
spacing of 1 mm in between. The agarose blocks were placed on ice for 5-10 mins to 
solidify. Slicing was performed using a Leica VT 1200S vibratome in ice-cold 
DMEM:F12 medium at 0.1 mm/s speed and 1 mm vibration amplitude. The 500 µm-
thick organoid slices were separated from the agarose by gentle pipetting. The section 
from the middle of an organoid were collected, while sections from the top and bottom 
ends were discarded. The organoid sections were transferred to 6-well plate with 
differentiation medium supplemented with 1% Matrigel (v/v), left to equilibrate for 1 hr 
in stationary culture and placed on a CO2 resistant orbital shaker rotating at 120 rpm in 
the incubator. After Day 70, the medium was switched to maturation medium and 
organoids can be maintained for up to a year with medium change every 2 days. Repeated 
slicing was performed every 4 weeks after initial slicing to prevent disk-shaped SNOs 
from growing back to spherical or oval shape. During embedding, SNOs were carefully 
oriented in the agarose mold to ensure that the x-y horizontal plane is parallel to the 
previous slicing plane, and when necessary, the positions and orientation of SNOs were 
 
65 
adjusted under a stereo microscope (Zeiss Discovery V8). After slicing, only one 500 
µm-thick section in the middle were collected and cultured following the procedures 
described above. After Day 35, the time schedule for SNO cultures was followed with a 
flexibility range of ± 3 days. SNOs were collected using a cut P1000 pipette tip when 
used for analyses on the indicated age (± 3 days). 
5.2.2 - Tissue preparation 
Whole organoids were fixed in 4% Paraformaldehyde in Phosphate Buffered 
Saline (PBS) for 30 mins at room temperature. Organoids were washed 3 times with PBS 
and then immersed in 30% sucrose solution overnight. Organoids were embedded in 
tissue freezing medium and sectioned with a cryostat (Leica) at 30 µm thickness unless 
otherwise specified. The disk-shaped SNOs were oriented carefully in the tissue freezing 
medium to ensure that the x-y horizontal plane is parallel to the section plane. The first 
and last 5 sections for each SNO were not used for any immunohistochemistry analysis.  
5.2.3 - Immunohistochemistry and microscopy 
For immunostaining, cryosectioned slides were washed with PBS before 
permeabilization with 0.5% Triton-X in PBS for 1 hr. Tissues were blocked with 
blocking medium consisting of 10% donkey serum in PBS with 0.05% Triton-X (PBST) 
for 30 mins. Primary antibodies diluted in blocking solution were applied to the sections 
overnight at 4 ºC. The primary antibodies used and their dilution were summarized in the 
Key Resource Table. After washing with PBST for a minimum of 5 times, secondary 
antibodies diluted in blocking solution were applied to the sections for 1-4 hrs at room 
temperature or overnight at 4 ºC. Finally, sections were washed with PBST for a 
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minimum of 5 times before mounting. Secondary anti-bodies were: AlexaFluor 488, 546, 
594, or 647 -conjugated donkey antibodies (Invitrogen) used at 1:500 dilution. Images 
were captured by a confocal microscope (Zeiss LSM 800). Sample images were prepared 
in ImageJ (NIH) and Photoshop (Adobe) software. 
5.2.4 - Analysis of hypoxia 
Detection of hypoxic cells in unsliced organoids and SNOs was performed using 
Hypoxyprobe Kit (HPI). Pimonidazole HCL was added to culture medium at 200 µM 
working concentration, and incubated with organoids for 2 hrs before fixation for 
analysis. Immunochemical detection of hypoxic cells containing pimonidazole was 
performed following the manufacturer’s instructions. SNOs and unsliced organoids were 
analyzed at Day 60, 110 and 140. All three dates were 2 weeks after a routine slicing for 
SNOs to ensure consistency. Only the cryosections in the very middle of the organoids 
were used for this analysis. Images were captured by a confocal microscope (Zeiss LSM 
800) using the same acquisition parameters (laser intensity and gain), and “tile”/ 
“stitching” functions in the Zen software (Zeiss) were used when necessary. To quantify 
the percentage of hypoxic area in sliced and unsliced organoids, the area labeled by the 
hypoxyprobe were measured using ImageJ software and divided by the total organoid 
area marked by DAPI.  
5.2.5 - Analyses of cell death 
For quantification of necrotic area in SNOs and unsliced organoids, organoid 
cryosections were immunostained with Cleaved-Caspase-3 (Cas3) and SOX2. Only 
sections in the middle were analyzed. The entire organoid section was imaged using a 
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confocal microscope, and “tile”/ “stitching” functions in the Zen software (Zeiss) were 
used when necessary. The necrotic area was defined as the interior portion of the 
organoid marked by: (1) diffusive non-cell-specific signals of Cas3 immunoreactivity; (2) 
absence of SOX2+ cells and (3) fragmented nuclei morphology stained by DAPI. The 
total area and necrotic area of an organoid was manually drawn and measured using 
ImageJ software. For quantification of the percentage of apoptotic cells, random cortical 
structures outside the necrotic area were imaged under a confocal microscope at single z-
plane. A randomly selected 400x400 µm area containing both the progenitor and 
neuronal layers was analyzed. The number of cells positive for Cas3 were counted and 
divided by the total cell number labeled by DAPI using ImageJ software.  
5.2.6 - Analyses of Layer thickness 
Analyses of progenitor zone thickness, cortical plate/subplate (CP) thickness and 
total thickness were performed similarly to previously described (Qian et al., 2016). Only 
cryosections near the middle of each organoid were used for analyses. SNOs and unsliced 
organoids were immunostained for SOX2, TBR2 and CTIP2. Random cortical structures 
were imaged under a confocal microscope and 15 µm z-stacks were projected with 
maximum intensity in ImageJ software. The ventricular zone (VZ) was defined by 
exclusive SOX2 immunoreactivity and neural tube-like morphology. The outer 
subventricular zone (oSVZ) was defined by the region containing mixed population of 
SOX2+, CTIP2+ and TBR2+ nuclei outside the VZ. The CP was defined by the region 
from the boundary of the oSVZ to the outer surface containing exclusively CTIP2+ 
nuclei. After defining the boundaries of each layer, the layer thickness was measured in 
the direction with maximum radial distance from the ventricular (apical) surface to the 
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pial (basal) surface using ImageJ software. For old organoids (typically >120 day) where 
the VZ shrunk in size and became difficult to define morphologically, the apical surface 
was defined at the center of the progenitor zone. The progenitor zone thickness was the 
sum of VZ and oSVZ, and the total thickness was the sum of progenitor zone and CP 
thickness.  
5.2.7 - Progenitor cell proliferation analyses 
For quantification of cell proliferation, SNOs and unsliced organoids were 
immunostained for SOX2 and KI67. Random cortical structures were imaged using a 
confocal microscope. A fan-shaped region from the apical surfaces of the VZ to the 
boundary between the oSVZ and CP were cropped for analyses. KI67+ nuclei were 
counted and divided by the total number of nuclei stained by DAPI in the region.  
5.2.8 - EdU labeling and quantification of cell identity 
SNOs at Day 70, Day 100 or Day 145 were pulsed with 10 μM EdU for 1 hr. The 
media was then replaced and SNOs were washed 3 times with fresh media to remove 
residual EdU. After 7 days, SNOs were fixed for immunohistochemistry and EdU 
detection using Click-iT® EdU Alexa Fluor® 488 Imaging Kit according to the 
manufacturer’s manual. Cortical structures were randomly imaged under a confocal 
microscope at the single z-plane. Each EdU-positive nucleus in the insets were traced in 
Photoshop software (Adobe), and manually assigned pseudo-colored to indicate whether 
it expresses SATB2 or CTIP2, or both.  
Day 95 SNOs were pulsed with 10 μM EdU for 24 hr and analyzed 3 or 7 days 
later. The number of EdU+ expressing SOX2, SATB2, and TBR2 were counted in ImageJ 
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software. The positions of all EdU+ nuclei were manually marked using the “Cell 
Counter” plugin in ImageJ. Their y-coordinates on the image were recorded and 
normalized to the total thickness from apical to basal surfaces of cortical structures to 
measure their relative laminar positions. The frequency distributions of the relative 
vertical positions in 11 evenly divided bins for each marker were calculated and plotted 
in Prism software (GraphPad). 
Day 95 SNOs were pulsed with 10 μM EdU for 24 hr and analyzed 28 days later 
(Day 123). The organoids were treated with DMSO, IWR or CHIR from Day 103 to Day 
123. The number of EdU+ expressing TBR1, SATB2, and co-expressing both were 
counted in ImageJ software. The ratio of co-expression was calculated by [#TBR1+ 
SATB2+ EdU+ nuclei / #SATB2+ EdU+ nuclei] and by [#TBR1+ SATB2+ EdU+ nuclei / 
#EdU+ nuclei]. Each EdU-positive nucleus in the insets were traced in Photoshop 
software (Adobe), and manually assigned pseudo-colored to indicate whether it expresses 
SATB2 or TBR1, or both. 
5.2.9 - Analyses of cortical neuron distribution  
SNOs were immunostained for SATB2 and TBR1 and random cortical structures 
were imaged on a confocal microscope at the single z-plane. From the pial surface, radial 
columns of 100 µm width and 200-500 µm length covering the full thickness of the CP 
layer were cropped for analyses. The positions of all SATB2+, TBR1+ and double-
positive nuclei were separately marked using the “Cell Counter” plugin in ImageJ. Their 
y-coordinates on the image were recorded and normalized to the full thickness of the CP 
to measure their relative laminar positions in the CP. The frequency distributions of the 
relative vertical positions in 11 evenly divided bins for each marker were calculated and 
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plotted in Prism software (GraphPad). The ratio of co-expression was calculated by 
[#TBR1+ SATB2+ nuclei / #SATB2+ nuclei]. For highlighting the differences between 
the relative cell numbers of SATB2+ nuclei and TBR1+ nuclei within each bin, heatmap 
was plotted in Prism software to represent [(normalized SATB2+ nuclei #) – (normalized 
TBR1+ nuclei #)], with red indicating a positive value (more SATB2) and blue indicating 
a negative value (more TBR1). The analyses for RORB and CTIP2, and additional 
neuron markers were performed similarly. Kolmogorov-Smirnov tests were performed 
using a web-based tool (http://www.physics.csbsju.edu/stats/KS-test.n.plot_form.html). 
The relative locations of all marker+ nuclei were used to plot the cumulative distribution 
curve and calculate the P-values.  
For the β-Catenin agonist/antagonist treatment experiments, CHIR99021 or IWR-
1-endo were added to the maturation medium at the specified concentrations to SNOs at 
Day 100 with medium change every 2 days. After 20 days (Day 120), random SNOs 
were collected for analysis while the remaining SNOs were washed and cultured in fresh 
medium without the drugs. The remaining SNOs were collected at Day 150 for analyses.  
5.2.10 - Viral infection 
For sparse labeling of radial glia cells and astrocytes with GFP, AV-CMV-GFP 
adenovirus (Vector Biolabs, titer = 1x1010 PFU/ml) were added into maturation medium 
at 1:2000 dilution, and incubated with SNOs for 24 hrs before being washed away. SNOs 
were analyzed 3- 5 days after exposure to virus, as indicated in figure legends, and 
immunohistochemistry against GFP was used to enhance the fluorescence signals.  
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5.2.11 - Single-nucleus RNA-seq and data analysis 
Single-nucleus RNA sequencing was performed following the SPLiT-seq method 
with minor modifications (Rosenberg et al., 2018). Nuclei isolated from fresh organoids 
was performed as previously described (Su et al., 2017). Briefly, Tissue were minced 
with a razor blade and homogenized using a tissue grinder in a 1 ml of HB buffer (1 mM 
DTT), 0.15 mM spermine, 0.5 mM spermidine, EDTA-free protease inhibitor, 0.3% 
IGEPAL-630, 0.25 M sucrose, 25 mM MgCl2, 20 mM Tricine-KOH) for 5 to 10 strokes, 
then filtered through a 40 m strainer, underlayer with a cushion buffer (0.5 mM MgCl2, 
0.5 mM DTT, EDTA-free protease inhibitor, 0.88 M sucrose) and centrifuged at 2800g 
for 10 minutes in a swinging bucket centrifuge at 4 ºC. Nuclei were collected as pellets.  
Nuclei were then centrifuged for 3 mins at 500g at 4 ˚C. The pellet was 
resuspended in 1 ml of cold PBS-RI (1x PBS + 0.05U/μl RNase Inhibitor). The nuclei 
were passed through a 40 μm strainer. 3 ml of cold 1.33% formaldehyde solution was 
then added to 1 ml of cells. Nuclei were fixed for 10 mins before adding 160 μl of 5% 
Triton X-100. Nuclei were then permeabilized for 3 mins and centrifuged at 500g for 3 
mins at 4 ˚C. Nuclei were resuspended in 500 l of PBS-RI before adding 500 μl of cold 
100 mM Tris-HCl pH 8. Then, nuclei were spun down at 500g for 3 mins at 4 ˚C and 
resuspended in 300 μl of cold 0.5 X PBS-RI. Finally, nuclei were again passed through a 
40 μm strainer and then counted on a hemocytometer, diluted to 1,000,000 cells/ml.  
mRNA from single nuclei were tagged 3 rounds with barcoded primers, with in-
cell ligations using T4 DNA ligase. Plates were incubated for 30 mins at 37 ºC with 
gentle sharking (50 rpm) to allow hybridization and ligation to occur. The ligation 
products were purified with Dynabeads MyOne Streptavidin C1 beads. After washing 
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beads once with 10 mM Tris and 0.1% Tween-20 solution and once with water, beads 
were resuspended into a solution containing 110 μl of 2X Kapa HiFi HotStart Master 
Mix, 8.8 μl of 10 μM stocks of primers BC_0062 and BC_0108, and 92.4 μl of water. 
PCR thermocycling was performed as follows: 95 °C for 3 mins, then five cycles at 98 °C 
for 20 seconds, 65 °C for 45 seconds, 72 °C for 3 mins. After these five cycles, 
Dynabeads beads were removed from PCR solution and EvaGreen dye was added at a 1X 
concentration. Samples were again placed in a qPCR machine with the following 
thermocycling conditions: 95 °C for 3 mins, cycling at 98 °C for 20 seconds, 65 °C for 20 
seconds, and then 72 °C for 3 mins, followed by a single 5 mins at 72 °C after cycling. 
Once the qPCR signal began to plateau, reactions were removed.  
PCR reactions were purified using a 0.8X ratio of KAPA Pure Beads and cDNA 
concentration was measured using a qubit. For tagmentation, a Nextera XT Library Prep 
Kit was used. 600 pg of purified cDNA was diluted in water to a total volume of 5 μl. 10 
μl of Nextera TD buffer and 5 μl of Amplicon Tagment enzyme were added to bring the 
total volume to 20 μl. After mixing by pipetting, the solution was incubated at 55°C for 5 
mins. A volume of 5 μl of neutralization buffer was added and the solution was mixed 
before incubation at room temperature for another 5 minutes. PCR was then performed 
with the following cycling conditions: 95 °C for 30 seconds, followed by 12 cycles of 95 
°C for 10 seconds, 55 °C for 30 seconds, 72 °C for 30 seconds, and 72 °C for 5 mins after 
the 12 cycles. 40 μl of this PCR reaction was removed and purified with a 0.7X ratio of 
SPRI beads to generate an Illumina-compatible sequencing library.  
Sequencing was performed with 50 bp paired end sequencing by Illumina 
NextSeq 550. Data processing was preprocessed using Drop-seq-1.13 (Macosko et al., 
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2015) with modifications. Briefly, after mapping the reads to the human genome (hg38, 
Gencode release V28), both exonic and intronic reads mapped to the predicted strands of 
annotated genes were retrieved for the cell type classification. Uniquely mapped reads 
were grouped by cell barcode. To digitally count gene transcripts, a list of UMIs in each 
gene, within each nucleus, was assembled, and UMIs within ED = 1 were merged 
together. The total number of unique UMI sequences was counted, and this number was 
reported as the number of transcripts of that gene for a given nucleus. Raw digital 
expression matrices were generated for the 1 sequencing runs. The raw digital expression 
matrices were combined and loaded into the R package Seurat (v 2.3.4) (Butler et al., 
2018). For normalization, UMI counts for all nuclei were scaled by library size (total 
UMI counts), multiplied by 10,000 and transformed to log space. As a result, 6888 nuclei 
were kept for further analysis.  
For clustering, the highly variable genes were identified using the function 
FindVariableGenes with the parameters: x.low.cutoff = 0.01, x.high.cutoff = 3 and 
y.cutoff = 0.8 in Seurat, resulting in 2,677 highly variable genes. The expression level of 
2,677 genes in the nuclei was scaled and centered along each gene, and was conducted to 
the PCA. We selected different cut-offs of the number of PCs and empirically found that 
downstream clustering analyses were optimized when using 25-PCs cutoff. First 25 PCs 
were selected and used for two-dimension t-distributed stochastic neighbor embedding 
(tSNE), implemented by the Seurat software with default parameters. Based on the tSNE 
map, 12 clusters were identified using the function FindCluster in Seurat with the 
resolution parameter of 0.6. To identify marker genes, differential expression analysis 
was performed by the function FindAllMarkers in Seurat with likelihood-ratio test. 
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Differentially expressed genes that were expressed in at least 10% cells within the cluster 
and with a fold change more than 0.5 (log scale) were considered to be marker genes.  
To compare cell-type classifications between organoid data and single-cell RNA-
seq data of second trimester human fetal prefrontal cortex, we first downloaded the raw 
UMI count matrix from Zhong et al. 2018 (Zhong et al., 2018). Using identical clustering 
parameters in Seurat defined above for the organoid analysis, we identified 11 clusters in 
the human fetal cortex dataset that were annotated based on the expression and 
enrichment of known biologically-relevant marker genes. Using the R package ClustifyR, 
we converted the fetal cortex dataset Seurat object into a cluster-specific average 
expression matrix using the function “use_seurat_comp” and considered only the highly 
variable genes in the output expression matrix. Using the function clustify in clustifyR 
with the argument compute_method = “pearson”, we computed the cluster-specific 
Pearson correlation coefficients between the organoid dataset and the Zhong et al. 
average expression matrix. 
To compare the astroglial cells in SNOs to fetal and postnatal human primary 
astrocytes, we obtained bulk RNA-seq data sets from a published study (Zhang et al., 
2016). Differential Expression analysis was performed using edgeR (v2.15.0), from 
which we generated two lists of top 50 genes highly expressed by fetal and postnatal 
astrocytes. The relative expressions of these genes were plotted for the single nuclei in 
AG cluster from our SNO dataset.  
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5.2.12 - Whole-cell recording in SNO slices 
SNOs were sliced into 200 µm thick section on a vibratome following procedures 
described above. Slices were placed in maturation medium in the incubator to recover for 
30 mins and then transferred into a recordings chamber perfused with ACSF solution 
consisted of 130 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 26 mM NaHCO3, 10 mM 
glucose, 1 mM MgCl2, and 2 mM CaCl2 (pH 7.2–7.4 when saturated with 95% O2/5% 
CO2). The osmolarity of all solutions was 305–315 mOsm. Slices were viewed using 
infrared differential interference contrast optics under an upright microscope (Slice Scope 
Pro, Scientifica) with a 40x water-immersion objective. Whole-cell postsynaptic patch-
clamp recordings were made using glass pipettes of 4–8 MΩ resistance, filled with an 
internal recording solution of the following (in mM):145 K-Gluconate, 2 MgCl2, 0.1 
BAPTA, 2.5 KCl, 2.5 NaCl, 10 HEPES, 0.5 GTP. Tris, 2 Mg-ATP, 2 QX-314, pH: 7.2, 
280–290 mOsm. In combination with the electrophysiological recordings we added 0.2% 
biocytin to the internal solution in order to label the patched neurons. Recordings were 
digitized at 20 kHz with Digidata 150A (AxonInstruments/Molecular Devices UnionCity, 
CA). Access resistance and leak currents were monitored and data were discarded if 
either parameter changed by >25% over the course of data acquisition. Spontaneous 
excitatory postsynaptic potentials currents (sEPSCs) were recorded at a holding potential 
of -70 mV for 10 mins. Data were analyzed off-line using Clampfit (Molecular Devices) 
and Prism 7.0 (GraphPad).    
5.2.13 - Extracellular recording and analyses 
Intact SNOs were transferred from maturation medium to BrainPhys neuronal 
medium (Bardy et al., 2015) supplemented with SM1, 10 ng/ml GDNF, 10 ng/ml BDNF 
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and 1X Penicillin/Streptomycin and cultured for at least 7 days prior to the recordings. 
Day 170 ± 5 SNOs were randomly selected and transferred to a Slotted Bath Oocyte 
Recording Chamber (Warner Instruments) containing BrainPhys medium. Throughout 
the recording, SNOs were constantly perfused with medium (roughly 2 ml/min) heated 
using a temperature controller (Warner Instruments) to maintain a constant temperature 
of 37 ºC (± 2 ºC) in the recording chamber. A 4-shank, 64-channel, Buzsaki style 
electrode (E-Series, Cambridge NeuroTech; 300 μm electrode coverage, 250 μm shank 
spacing) was slowly inserted into the SNO using a micromanipulator (Kopf) until all 
contacts were in the SNO. Wide bandwidth signals from the electrodes were amplified 
using a headstage (Neuralynx), digitized with a Digital Lynx 4SX control system 
(Neuralynx) at 32 kHz, and bandpass filtered at 0.1 to 9 kHz with Cheetah acquisition 
and recording software (Neuralynx). In parallel, electrode sites were artificially grouped 
into tetrodes and multi-unit activity was visualized on each tetrode online in the Cheetah 
software. Briefly, signals from each electrode site were filtered from 0.6-6 kHz online 
using a tap finite impulse response (FIR) filter, and a threshold was set (20-25 μV in our 
setup) to be just above noise levels in the system. Anytime a signal crossed the user-
defined threshold value, the next inflection point in the filtered signal was found and set 
as the alignment point. A 1 ms recording (comprising of 32 samples) from all 4 
electrodes that made up the tetrode was obtained such that the sample alignment point 
made up the 8th of 32 samples. Once multiunit activity was observed in the Cheetah 




Single unit clusters were initially isolated from the 1 ms filtered, thresholded 
recordings using an unsupervised masked expectation-maximization (EM) algorithm that 
uses principle component analysis of spike features to sort spikes (KlustaKwik) (Kadir et 
al., 2014). Clusters were further refined by merging or hand-cutting output clusters from 
KlustaKwik based on differential spike shape between electrodes within a tetrode using 
SpikeSort3D software (Neuralynx). Once single units were separated, data was imported 
into Matlab software (MathWorks) or NeuroExplorer software (Plexon) and analyzed 
using custom and built-in routines. Inter-spike interval histograms (20 bins per decade) 
and auto-correlograms (bin size = 5 ms) were created to visualize interactions within 
neurons, and cross-correlograms (bin size = 5 ms) were created to visualize interactions 
between different neurons. 
5.2.14 In vitro induction of cortical folding using ECM factors 
The induction of wrinkles in the CP in slice-cultured SNOs was performed 
following published methods for human cortical slices with some modifications (Long et 
al., 2018). SNOs at Day 95, 110 or 125 were further sliced into 200 µm thick sections 
using a vibratome following similar procedures described above. Each section was cut in 
half at the midline with a scalpel to mimic the shape of an organotypic cortical slice used 
in the published study (Long et al., 2018). Sections were resuspended in a human 
collagen I-based hydrogel supplemented with 5 µg/mL recombinant human HAPLN1 and 
5 µg/ml recombinant human lumican for the “LHC” condition, the equivalent volume of 
PBS was added to the hydrogel solution for the control condition. Droplets of hydrogel 
solution each containing one SNO section was placed on a glass-bottom petri dish 
(Matek) and incubated in the incubator for 30 mins before 3 ml of maturation medium 
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was added to the dish. The embedded sections were then cultured in the stationary culture 
for an addition 2 to 4 days before analyses. Fixed sections were cryosectioned in the 
parallel direction for immunohistochemistry analyses. The CP of SNO sections was 
imaged using a confocal microscope and the gyrification index was calculated by [inner 
length/ outer length]. 
5.2.15 - Transcriptomic analyses of iPSC-derived neurons 
Previously published RNA sequencing data from our group (Wen et al., 2014) on 
cortical neurons derived from the same D2 and C3 iPSC lines used in the current study 
was re-analyzed to evaluate the differences in the WNT/β-Catenin signaling pathway 
genes in relatively pure cortical neuron populations. Reads covering gene coding regions 
were counted with BEDTools and count data were analyzed for differential expression 
using edgeR (v2.15.0). The list of WNT pathway related genes was obtained from KEGG 
pathway (https://www.genome.jp/kegg/pathway/hsa/hsa04310.html). 
5.2.16 - QUANTIFICATION AND STATISTICAL ANALYSIS 
Individual organoids are treated as biological replicates, unless otherwise 
indicated in the Figure Legends. Data are presented as mean ± S.E.M. or mean + S.D., 
unless otherwise indicated in the Figure Legends. Statistical analyses were performed 
using the Student’s t-test in Excel or Prism software. Significance was defined by P-value 
< 0.05. Organoid samples were randomly taken from the culture for experiments and 
analysis. Sample sizes are determined empirically. The sample sizes are designed to 
account for the variability between organoids and human iPSC cell lines and match 
current standards in human brain organoid-related studies. Other statistical details of 
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experiments can be found in the Figure Legends. Data analyses comparing control and 
disease individual-derived organoids were performed blindly. Data analyses comparing 
sliced and unsliced organoids were not performed blindly because the visual difference 
between the two group is striking, and blinding is not possible to an informed researcher. 




5.3 - Results 
5.3.1 - Slicing Method Resolves Interior Hypoxia and Reduces Cell Death in Cortical 
Organoids  
In order to generate cortical organoids to model late-stage developmental features, 
such as the formation of distinct upper and deep cortical layers, we aimed to sustain 
neurogenesis and support the expansion of cortical structures over long-term cultures. We 
reasoned that the diffusion limit is inevitable if the organoid is cultured as a sphere 
without functional circulation systems. Therefore, we developed a precisely controlled 
slicing method to “trim” the organoid into a disk shape and expose the interior to the 
external culture environment (Figure 9A). We followed our previously established 
forebrain organoid protocol to Day 45 (Day 0 refers to when human iPSC colonies were 
detached to form embryoid bodies), when organoids have formed large ventricular 
structures and organized radial glia scaffolds (Qian et al., 2018). The forebrain organoids 
were then embedded in low-melting-point agarose and sectioned into 500 μm-thick slices 
using a vibratome (Figure 9A). Organoid slices came off the agarose after sectioning 
spontaneously or with gentle pipetting, and were collected and transferred to a 6-well 
plate and cultured on an orbital shaker. From a spherical organoid with 1.5 mm diameter, 
the one or two slices in the middle plane were kept for culture. These disk-shaped 
organoids received oxygen and nutrients by diffusion through the exposed top and bottom 
surfaces, permitting growth in both horizontal (x-y) and thickness (z) directions while 
maintaining the organization of cortical structures (Figure 9B-C). To keep the organoid 
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thickness under the diffusion limit over the course of long-term culture, they were 
repeatedly sliced to 500 μm every 4 weeks in the parallel plane to the first slicing. From 
Day 60 to Day 140, the slicing method substantially reduced the pronounced interior 
hypoxia present in unsliced organoids, as revealed by hypoxic cell detection using a 
pimonidazole-based probe assay (Varia et al., 1998) (Figure 9D-E). The 500 μm section 
thickness was larger than the diameter of most ventricular structures formed within 
organoids, allowing the ventricular zone (VZ) to maintain intact adherens junctions at the 
apical surface (Figure 9F). Compared to unsliced forebrain organoids, these sliced 
neocortex organoids (hereafter referred to as SNOs) showed a drastically reduced 
necrotic area size, which did not increase over time. Moreover, this approach also 








Figure 9. Sliced Neocortical Organoid (SNO) Method Reduces Cell Death by Resolving 
Interior Hypoxia 
(A) Schematic illustration for the SNO protocol and culture timeline. 
(B) Sample bright-field images of an SNO captured at Day 45, 70, 95 and 140. Day 0 
refers to when iPSC colonies were detached to form embryoid bodies. Scale bar, 500 µm. 
(C) Sample immunostaining confocal images of SNOs showing the maintenance of 
cortical structures after slicing. Scale bars, 100 µm. 
(D and E) Hypoxia assay comparing unsliced organoids and SNOs using a 
pimonidazole-based hypoxia probe. Sample tiling confocal images for unsliced organoids 
and SNOs at Day 60, 110 and 140 show hypoxic cells in purple, and DAPI in white (D). 
Scale bars, 200 µm. Images at the same date are shown at the same scale. Shown in (E) 
is the quantification of the percentage of hypoxic area over total organoid area. Bar 
values represent mean ± S.D. (n = 5 organoids; ***p < 0.0005, Student’s t test). 
(F and G) Analyses of apoptotic cell death in SNOs and unsliced organoids. Shown are 
sample immunostaining confocal images for apoptosis marker cleaved caspase-3 (Cas3) 
and adherens junction marker PKCλ (F), and quantification of apoptotic cell death 
within the non-necrotic region (G). Scale bar, 100 µm. Values represent mean ± S.E.M. 
(n ≥ 10 and 5 organoids for SNOs and unsliced organoids, respectively; ***p < 0.0005, 




5.3.2 - SNO Method Sustains Neurogenesis and Radial Migration of New-born Neurons 
Over long-term culture and repeated slicing, SNOs continued to grow. At Days 
100 and 150, the oSVZ-like structures contained a large population of HOPX+ oRG-like 
NPCs with radially aligned basal processes contacting the pial surface, and expanded to 
several folds larger than the VZ, similar to human embryonic cortex in the second 
trimester (Lui et al., 2011) (Figure 10A). The oSVZ also contained abundant TBR2+ 
intermediate progenitor cells (IPCs) committed to glutamatergic neuron neurogenesis 
(Figure 10B). In contrast, both KI67 and TBR2 were sparsely detected in unsliced 
organoids by Day 150, suggesting depletion of neurogenic progenitors (Figure 10A-B). 
Quantitative analysis also showed that progenitor proliferation was sustained steadily in 
SNOs and substantially increased over unsliced organoids at Days 120 and 150 (Figure 
10C). The size of progenitor zones continued increasing in SNOs, unlike the shrinkage 
seen in unsliced organoids (Figure 10D). Sparse labeling using adenovirus expressing 
GFP showed that the majority of radial glia cells expressed multiple human oRG markers 
(Pollen et al., 2015) and exhibited the hallmark unipolar morphology of oRGs (Figure 
10E). Birth-dating of newborn cells using 5-ethynyl-2'-deoxyuridine (EdU) pulse-chase 
labeling for 7 days confirmed sustained production of cortical neurons (Figure 10F). At 3 
days post-labeling at Day 95, the majority of EdU+ cells were SOX2+ and located within 
the oSVZ (Figure 10H-J). At 7 days post-labeling, post-mitotic cells retaining strong EdU 
reactivity moved up into the CP and expressed cortical neuron marker SATB2, while 
cycling progenitors expressing SOX2 and TBR2 underwent multiple divisions and their 
EdU immunoreactivity became undetectable due to dilution (Figure 10H-J). Moreover, 
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many EdU+ cells found within the oSVZ also expressed PRDM8, a marker for migrating 
neurons in the cerebral cortex (Inoue et al., 2014; Komai et al., 2009). PRDM8 was more 
abundantly detected in the oSVZ than in the CP, suggesting that the majority of neurons 








Figure 10. Sustained Neurogenesis and Radial Migration of New-born Neurons in SNOs 
(A and B) Sample tiling confocal images showing the oSVZ of Day 150 SNOs (top) and 
unsliced (bottom) organoids, immunostaining for proliferation marker KI67, general 
NPC marker SOX2, oRG marker HOPX (A), and IPC marker TBR2 (B). HOPX+Ki67+ 
cells are proliferating oRGs, and TBR2+Ki67+ cells are transient-amplifying IPCs. Scale 
bars, 100 µm. 
(C) Quantification of the percentage of KI67+ cells in the progenitor zones (VZ and 
oSVZ) within SNOs and unsliced organoids at different time points. Values represent 
mean ± S.E.M. (n = 5 organoids; n.s.: p > 0.05, **p < 0.005, Student’s t test). 
(D) Quantification of the size of the proliferative progenitor zones in SNOs and unsliced 
organoids. Values represent mean ± S.D. (n ≥ 20 and 10 organoids for SNOs and 
unsliced organoids from 2 iPSC lines, respectively; n.s.: p > 0.05, **p < 0.005, ***p < 
0.0005, Student’s t test). 
(E) Adenovirus expressing GFP preferentially infects oRG-like cells with unipolar 
morphologies and basal processes contacting the pial surface. Shown on the left is a 
sample tiling confocal image for a Day 120 SNO with two large oSVZ structures. The 
inset shows magnified view with a 90-degree counter-clockwise rotation. Scale bars, 100 
µm. 
(F) Sample confocal images for 7-day EdU pulse-chase experiments, with newborn 
neurons labeled double-positive for EdU and neuron marker CTIP2 or SATB2 in SNOs at 
Day 70, 107 and 152. Scale bars, 100 µm and 50 µm in insets. EdU+ nuclei in the insets 
(bottom right panels) are pseudo-colored to indicate their marker expression: Grey 
(SATB2-, CTIP2-); Red (SATB2+, CTIP2-); Blue (SATB2-, CTIP2+); Purple (SATB2+, 
CTIP2+).  
(G) Sample confocal images for 3- and 7-day EdU pulse-chase experiments, showing that 
EdU+ cells migrated from the SOX2-enriched progenitor zones to the SATB2-enriched 
CP from Day 98 to Day 102. Scale bar, 100 µm. 
(H) Quantification of the percentage of EdU+ cells expressing neuron marker SATB2, 
NPC marker SOX2, or IPC marker TBR2, at 3 and 7 days post-EdU labeling on Day 95. 
Values represent mean ± S.E.M. (n = 5 organoids for each marker). 
(I) Quantifications of the localization of EdU+ cells at 3 and 7 days post-EdU labeling, 
showing a shift towards the basal direction. The cortical structure from apical surface to 
basal surface is evenly divided into bins 0-10. Shown are curves representing the 
normalized abundance within each bin, calculated as [# of EdU+ cell in a bin/# of total 





5.3.3 - Layer Expansion Persists in SNOs over Long-term Culture  
With improved cell viability and sustained neurogenesis, the laminar structures of 
SNOs continuously expand over long-term cultures, while maintaining the organization 
of progenitor zones and neuronal layers (Figure 11A). From Day 70 to Day 150, the 
cortical structures of SNOs displayed well-defined VZ, oSVZ and CP layers. The VZ was 
marked by densely packed SOX2+ NPCs at the apical side; the oSVZ contained mixed 
populations of NPCs, IPCs and CTIP2+ migrating neurons; and the CP at the basal side 
was exclusively populated by neurons forming condensed layers. We measured the total 
layer thickness of cortical structures by the distance between the apical (ventricular) 
surface to the basal (pial) surface. While the viable thickness in unsliced organoids was 
restricted to 300-400 μm and stopped increasing soon after Day 70, SNOs could 
consistently expand far beyond this limit (Figure 11B-C). At Day 150, the total layer 








Figure 11. Layer Expansion in SNOs over Long-term Cultures  
(A) Sample tiling confocal images of cortical structures in SNOs (top) and unsliced 
organoids (bottom), for immunostaining of CTIP2, SOX2 and TBR2 at Day 70, 100, 120 
and 150. Dashed lines mark the pial surfaces and the boundaries the ventricular zone 
(VZ), outer subventricular zone (oSVZ) and cortical plate (CP). The laminar structures in 
Day 120 and 150 unsliced organoids are disorganized, the thus not marked by dashed 
lines. Scale bar: 100 m. 
(B and C) Quantifications of the total thickness (B) and CP thickness (C) in SNOs and 
unsliced organoids. Values represent mean ± S.D. (n ≥ 10 and 5 organoids for SNOs and 
unsliced organoids for each cell line, respectively; *p < 0.05, **p < 0.005, ***p < 




5.5.4 - SNOs Form Distinct Upper and Deep Cortical Layers 
We next investigated whether improved cell viability and sustained CP expansion 
lead to the formation of separated cortical layers. Previously, we reported that the CP in 
unsliced forebrain organoids contained cortical neurons expressing upper and deep layer 
markers, but they did not separate into distinguishable layers, reminiscent of developing 
human cortex around gestational weeks (GW) 14 to 18 (Hevner, 2007; Qian et al., 2016). 
Similar to unsliced organoids, the CP of Days 70 and 100 SNOs contained both upper 
layer intracortical (callosal) projection neuron marker SATB2 and deep layer subcortical 
projection neuron marker TBR1 without layer preferences (Figure 12A). In contrast, 
when SNOs were cultured to Day 120 and beyond, the laminar distribution of the 
markers became layer specific. At Days 120 and 150, the upper layers were populated 
exclusively by SATB2+/TBR1- neurons, whereas the deep layers were dominated by 
TBR1+/SATB2- neurons, separated by a defined boundary (Figure 12A). We divided the 
thickness of the CP into 11 equally-sized bins to quantitatively analyze the laminar 
expression patterns of SATB2 and TBR1 (Figure 12B). At Days 70 and 100, the 
distributions of the two markers overlapped with each other, but at Days 120 and 150, 
they exhibited two separated peaks representing the upper and deep layers (Figure 12B).  
Importantly, we observed a sharp decrease in the percentage of neurons co-
expressing SATB2 and TBR1 over time: while 90.3 ± 4.7% of SATB2+ neurons co-
expressed TBR1 at Day 70, this percentage dropped to 10.7 ± 1.2% at Day 150 (Figure 
12C), suggesting post-mitotic fate specification of existing cortical neurons during the 
establishment of separated laminar expression domains. In some cases, the CP in Day 
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150 SNOs could be subdivided further to resemble the marker distribution and 
cytoarchitecture of Layers I to VI in the perinatal frontal cortex (Saito et al., 2011). These 
dynamic progressions in layer-specific marker expression and localization closely 
resemble the human neocortex in the third trimester (Saito et al., 2011). In addition, 
analyses for another pair of markers, RORB and CTIP2 (Nakagawa and O'Leary, 2003), 
depicted very similar establishment of laminar expression patterns specific to the upper 
and deep cortical layers after Day120 (Figure 12D-E). The ratio of co-expression 
between RORB and CTIP2 also decreased steeply over time (Figure 12F). We further 
analyzed the laminar distribution of additional known markers for cortical neuron 
subtypes (Lake et al., 2016), among which CUX1 and LAMP5 displayed exclusive 
localization in the superficial layers at Day 150, similar to their distribution in the adult 
human neocortex.  
In the rodent embryonic cortex, expression of SATB2 and CTIP2 directly controls 
axonal projection of cortical neurons (Britanova et al., 2008). Visualized by a general 
axon marker SMI312 (Ulfig et al., 1998), the CTIP2+ deep layer contained mostly 
vertically-oriented axons and the SATB2+ upper layer was filled by tangentially-oriented 
axons circling the organoids at Day 150. The boundary delineated by the tangential and 
vertical axonal patterns coincided with the boundary between SATB2 and CTIP2 
enriched domains, which is consistent with the notion that their projection patterns are 








Figure 12. Establishment of Separated Upper and Deep Cortical Layers and Specification 
of Cortical Neuron Subtypes  
(A) Sample immunostaining confocal images of the CP of SNOs for callosal projection 
neuron marker SATB2, and subcortical projection neuron marker TBR1 at Day 70, 100, 
120 and 150. Shown are cropped 100 x 300 µm columns in the CP, and the pial surface 
is at the top. Scale bar, 50 µm.  
(B) Quantifications of the distribution of SATB2+ and TBR1+ neurons in the CP. The CP 
is evenly divided into 11 bins, bins 0-10 follow apical-to-basal direction. Shown are 
curves representing the normalized abundance within each bin, calculated as [# of 
marker+ cell in a bin/# of total neurons]. Values represent mean ± S.E.M. (n = 10 
organoids from C1 and C3 iPSC lines). 
(C) Quantification of the ratio of co-expression of TBR1 and SATB2 over SATB2+ cells in 
the CP. Same samples as in (B). Values represent mean ± S.D. 
(D) Sample immunostaining confocal images of the CP of SNOs for upper layer neuron 
marker RORB, and deep layer neuron marker CTIP2 at Day 70, 100, 120 and 150. 
Shown are cropped 100 x 300 µm columns in the CP, and the pial surface is at the top. 
Scale bar, 50 µm.  
(E) Quantification of the distribution of RORB+ and CTIP2+ neurons in the CP. Similar 
to (B). Values represent mean ± S.E.M.  
(F) Quantification of the ratio of co-expression of RORB and CTIP2 over RORB+ cells in 
the CP. Same samples as in (E). Values represent mean ± S.D.  
(G) Sample confocal images of morphologically distinct GFAP+ astrocytes in Day 150 
SNOs. Scale bars, 100 µm. Note localization of interlaminar astrocyte cell body near the 
pia surface and protoplasmic astrocytes in the SATB2+ upper layer. 
(H) Graph-based clustering of cells from Day 150 SNOs by single-nuclei RNA-seq (n = 6,888 
nuclei). L1, Layer I; UL, Upper layer; DL, Deep layer; CN, Cortical neuron; AG, Astrocyte/glia; 
IPC, Intermediate progenitor cells; RG, Radial glia; DP, Dividing progenitors. Cell population 
identities were determined by gene enrichment analysis using cell type and layer-specific marker 
gene sets obtained from the Allen Brain Atlas (Hawrylycz et al., 2012) (http://human.brain-
map.org/) and published datasets of single-cell RNA-seq of the developing and adult human 
cerebral cortex (Fan et al., 2018; Lake et al., 2016; Nowakowski et al., 2017; Pollen et al., 2015).  
(I) The expression of selected cluster-specific marker genes used for cell type classification. 
Shown are violin plots overlaid on the scatter plots, where the proportion of cells expressing a 
given gene is the highest. The color coding for the gene names indicates the cluster in which the 




5.5.5 - SNOs Contain Diverse Cell Types 
In addition to excitatory neurons, various subtypes of GABAergic neurons were 
also sparsely detected in SNOs, including neurons expressing Somatostatin (SST), 
Calretinin (CR), nNOS, NPY, ChAT and Parvalbumin (PV). Moreover, immunostaining 
for GFAP revealed the presence of three morphologically distinct astrocyte subtypes, 
which displayed the hallmarks of the protoplasmic astrocytes, fibrous astrocytes and the 
primate/human-specific interlaminar astrocytes found in the human cerebral cortex 
(Figure 12G) (Hodge et al., 2019; Oberheim et al., 2009). In Day 150 SNOs, the subtype-
dependent laminar distributions of astrocytes also resemble that in the human cerebral 
cortex. The cell body of interlaminar-like astrocytes reside exclusively in the Layer 
I/Marginal zone and extended long descending processes into the CP, while the 
protoplasmic and fibrous-like astrocytes were located in the CP (Figure 12G). Sustained 
proliferation allowed for generation of oligodendrocyte precursor cells (OPC) and 
oligodendrocytes, the late-born cell types in the forebrain NPC lineage.  
To characterize the full repertoire of cell type diversity within SNOs, we 
performed single-nuclei RNA-seq analysis. Following the recently published SPiLT-seq 
method (Rosenberg et al., 2018), we analyzed 6,888 single nuclei from Day 150 SNOs. 
Unsupervised clustering of single cells was achieved by principal component analysis 
using highly variable genes, and was visualized on two-dimensional t-distributed 
stochastic neighbor embedding (tSNE) plot, from which we obtained 12 well-defined 
clusters (Figure 12H). Known layer- or subtype-specific cortical neuron markers, such as 
RELN (Cluster L1), SATB2 (Cluster UL1), CUX2 (Cluster UL2), BCL11B (CTIP2, 
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Cluster DL1), were specifically enriched in distinct clusters and EOMES (TBR2) was 
exclusively expressed in the IPC cluster (Figure 12I). Radial glia cell marker VIM and 
dorsal forebrain NPC marker PAX6 were expressed in the radial glia cell clusters (RG1, 
RG2 and DP) (Figure 12I). The dividing progenitor (DP) cluster is specifically enriched 
with MKI67 and other mitotic genes, and differential expression of NOTCH1 
distinguishes RG1 and RG2 clusters (Figure 12I ), as inhibition of Notch is an indicator 
for the differentiation state of oRGs (Hansen et al., 2010). In situ hybridization images of 
the adult human cortex obtained from the Allen Brain Atlas (http://human.brain-
map.org/) validated the layer-dependent expression patterns of selected marker genes 
used in the analyses. We compared SNO cells with embryonic human prefrontal cortex 
cells from a published scRNA-seq dataset to assess SNO’s similarity with the human 
fetal brain (Zhong et al., 2018). Pearson Correlation analyses between all SNO and fetal 
cell clusters showed SNO cell types most highly correlated to the corresponding 
endogenous cell types, indicating that their transcriptional profiles were similar to 
endogenous cells in the developing human prefrontal cortex. Because the fetal human 
dataset we obtained lacked a distinct astrocyte cluster, we separately compared the 
Astroglia (AG) cluster to another published dataset of bulk RNA-seq of human fetal and 
postnatal primary astrocytes (Zhang et al., 2016).  Surprisingly, the astrocytes in Day 150 
SNOs showed higher similarity to human postnatal astrocytes than to fetal astrocytes, 
suggesting astrocyte maturation may be accelerated in the SNO culture.  
To characterize the functional properties of neurons in SNOs, we performed 
electrophysiological analysis with whole-cell recording in slices acutely prepared from 
SNOs and detected spontaneous synaptic currents. Biocytin labeling after recording 
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revealed the complex morphology of neurons with dendritic spine structures and long 
tangentially-oriented axons extending for millimeters with branches into multiple regions 
in the CP , consistent with the axonal patterns revealed by the SMI312 immunostaining. 
At the circuitry level, extracellular recording of intact SNOs using a four-shank multi-
electrode laminar probe revealed spontaneous firing of action potential and coordinated 
burst patterns, indicative of network activities across long distances both vertically and 
horizontally. Among sets of coordinated single neurons detected several hundred 
micrometers apart, the order of single neuron recruitment and burst durations showed a 
repeatable temporal pattern, suggesting the presence of stably established connectivity. 
5.5.6 - WNT/β-Catenin Signaling Regulates Post-Mitotic Fate Specification of Cortical 
Neurons 
We next applied our SNO system to investigate molecular mechanisms regulating 
human neocortical development. The fate of cortical neurons is partially determined cell-
autonomously during neurogenesis, but the post-mitotic fate specification that refines 
neuronal subtype identity and establishes layer-specific gene expression is synergistically 
regulated by cell non-autonomous signaling (Fame et al., 2011; Greig et al., 2013; 
Molyneaux et al., 2007; Shepherd, 2013; Telley et al., 2019). The mechanisms regulating 
cortical neuron fate specification in humans have remained largely unclear due to the lack 
of an accessible and representative model. The WNT/β-Catenin pathway genes, including 
WNT7B, are specifically enriched in the deep layer and subplate in the human embryonic 
cortex during the late second trimester (Abu-Khalil et al., 2004; Miller et al., 2014). The 
WNT/β-Catenin signaling regulates the specification of subplate neurons into deep layer 
neurons by suppressing callosal projection fate and promoting the alternative subcortical 
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projection fate in a layer-specific manner (Ozair et al., 2018). Similar to its localization in 
vivo, WNT7B was enriched in the deep CP layers of SNOs, and progressively established 
mutually exclusive domains with the SATB2+ upper layer from Day 100 to Day 150 
(Figure 13A). Notably, the deep layer-specific enrichment of WNT7B was already 
apparent at Day 100, preceding the establishment of separated cortical layers, suggesting 
that WNT7B expression could regulate, but is not the result of cortical layer specification 
(Figure 13A). 
To investigate the functional role of WNT/β-Catenin signaling in cortical neuron 
fate specification, we treated Day 100 SNOs with either β-Catenin inhibitor IWR-1-endo 
(IWR) or β-Catenin activator CHIR99021 (CHIR) for 20 days between Day 100 to Day 
120, a time window with rapid changes in the laminar expression patterns of upper and 
deep layer markers (Figure 12A-F). SNOs treated with IWR showed an increase in 
SATB2 expression in the lower cortical bins, resulting in comparable abundance between 
SATB2+ neurons and TBR1+ neurons in the deep layers at Day 120 (Figure 13B-C). On 
the contrary, CHIR-treated SNOs showed a decrease in SATB2 expression, accompanied 
by substantial increase of TBR1 across the entire CP (Figure 13B-C). As a result, the 
expression patterns of SATB2 and TBR1 were overlapping and lost their respective 
preferences to upper and deep layers in drug-treated SNOs (Figure 13C-D). Interestingly, 
both IWR and CHIR treatments resulted in a significant increase in the percentage of 
neurons co-expressing TBR1 and SATB2, suggesting an impairment in neuronal fate 
specification (Figure 13E). Similarly, the drug treatment altered the laminar expression 
patterns of RORB and CTIP2 (Figure 13C). Elevation of RORB induced by IWR in the 
deep layer and elevation of CTIP2 induced by CHIR in the upper layer both disrupted the 
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respective layer-specificity of the two markers, concurring with an increased proportion 
of double-positive cells (Figure 13C and 13F).  
To determine whether the drug treatments affected postmitotic neurons or 
neurogenesis, we performed EdU-pulse chase labeling to specifically label neurons birth-
dated at Day 95. On Day 103 (8 days post-labeling), DMSO, IWR or CHIR were added 
to the culture medium. At 20 days after drug treatment, the ratio of co-expression 
between SATB2 and TBR1 among EdU+ neurons was elevated in both IWR and CHIR 
treated SNOs . Because EdU is diluted in cycling cells, cells retaining EdU after 28 days 
of pulse-chase are predominantly postmitotic neurons born within a few days after Day 
95, providing direct evidence that WNT/ β-Catenin controls post-mitotic fate 
specification of cortical neurons. Following the withdrawal of drug treatment at Day 120, 
the IWR-induced effects persisted, indicating that Day 100 to Day 120 may be a decisive 
time window for neuronal subtype fate specification. Together, these results showed that 
similar to the developing human cerebral cortex, SNOs rely on self-maintained layer-
dependent signaling to regulate the distinct laminar expression of neuron subtype 









Figure 13. Regulation of Cortical Neuron Fate Specification by WNT/β-Catenin 
Signaling  
(A) Sample confocal images of the CP of SNO at Day 70, 100, 120 and 150, 
immunostaining for SATB2, CTIP2 and secreted WNT signaling protein WNT7B. WNT7B 
progressively establishes enriched domains that is exclusive with SATB2, but overlapping 
with CTIP2. Scar bars, 100 µm. 
(B) Sample confocal images showing the effects of β-Catenin antagonist (IWR-1-endo, 
IWR) and agonist (CHIR9902, CHIR) on the expression patterns of SATB2 and TBR1 
neurons in the CP. Compounds were added into culture medium at the indicated 
concentrations from Day 100 to Day 120 and the analysis was performed at Day 120. 
Shown are cropped 100 x 300 µm columns from sample immunostaining confocal images 
of the CP for TBR1 and CTIP2. Scale bar, 50 µm.  
(C) Quantifications of the distribution of SATB2+, TBR1+ and RORB+, CTIP2+ neurons 
in the CP of SNOs treated with compounds. Shown on the left are curves representing the 
normalized abundance within each bin, similar to Figure 12B. Values represent mean ± 
S.E.M. (n = 10 organoids from 2 iPSC lines for DMSO and IWR treatments; n = 5 
organoids for CHIR treatments). Shown on the right are cumulative distribution curves of 
marker positive neurons. Kolmogorov-Smirnov tests were performed for the drug treated 
conditions, indicated by the corresponding color, against DMSO (n.s.: p > 0.05, *p < 
0.05, Kolmogorov-Smirnov tests). 
(D) Heatmap plots for the differential abundance between SATB2+ and TBR1+ in the CP 
of drug treated SNOs. Each row represents one of the 11 CP bins and each column 
represents individual SNO analyzed. The differences between the abundance of SATB2+ 
nuclei and TBR1+ nuclei within each bin is calculated as [(normalized SATB2+ nuclei #) 
– (normalized TBR1+ nuclei #)]. Red on the heatmap indicates a positive value (more 
SATB2) and blue indicates a negative value (more TBR1). The compound treatments 
resulted in the loss of the “top-red, bottom-blue” pattern found in DMSO-treated SNOs.  
(E and F) Quantifications of the ratio of co-expression between TBR1 and SATB2 over 
SATB2+ cells (E) and between RORB and CTIP2 over RORB+ cells (F) in compound-
treated SNOs. Same samples as in (C). Values represent mean ± S.E.M. (*p < 0.05, **p 




5.5.7 - Psychiatric Disorder Patient iPSC-derived SNOs Exhibit Cortical Neuron Fate 
Specification Deficits  
Disorganization of cortical lamination has been hypothesized to contribute to the 
etiology of neurodevelopmental disorders (Kana et al., 2011; Zikopoulos and Barbas, 
2013). For instance, in situ hybridization analyses revealed frequent patches of aberrant 
laminar expression patterns of cortical layer markers in frontal lobes of children with 
autism spectrum disorders (Stoner et al., 2014). The SNO system provides a platform to 
test the possibility that the developmental origins of other major psychiatric disorders 
could also involve similar abnormalities. Mutations of the DISC1 gene have been 
associated with schizophrenia, major depression and autism (Brandon and Sawa, 2011; 
Sachs et al., 2005). In NPCs and neurons, DISC1 protein inhibits GSK3β activity through 
direct physical interaction, resulting in the stabilization of β-catenin, and DISC1 loss-of-
function consequently impairs WNT/β-catenin signaling (Mao et al., 2009; Singh et al., 
2011). Previously, we derived iPSCs from fibroblasts of psychiatric disorder patients 
with a heterozygous 4 base-pair (bp) frameshift deletion at the DISC1 carboxy(C) 
terminus and reported that the mutant DISC1 (mDISC1) causes an 80% reduction of 
wild-type DISC1 (wtDISC1) protein levels in iPSC-derived cortical neurons (Chiang et 
al., 2011; Wen et al., 2014). Differential expression analyses of RNA-seq data comparing 
mDISC1 and control cortical neurons showed a significant downregulation of WNT/β-
Catenin pathway genes.  
We generated SNOs using mDISC1 iPSCs derived from two patients with 
psychiatric disorder and carrying the DISC1 mutation (D2 and D3) to compare with 
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control SNOs using iPSCs derived from a member of the same family without the DISC1 
mutation (C3) and a control iPSC line from outside of the family (C1) (Chiang et al., 
2011; Wen et al., 2014). The mDISC1 SNOs did not exhibit differences in differentiation 
and growth compared to controls. They showed normal levels of apoptotic and necrotic 
cell death, formed organized progenitor zones and CP, and the layer size expansion 
closely mirrored control SNOs at all time points examined, further supporting the 
reproducibility of the SNO method.  
The CP of mDISC1 SNOs resembled control SNOs at Days 70 and 100, when the 
distributions of SATB2 and TBR1 were intermingled without noticeable segregation 
(Figure 14A-C). However, unlike the control, the laminar expression of SATB2, TBR1, 
RORB and CTIP2 in Day 120 mDISC1 SNOs from both patient lines lost layer-
specificity and remained intermingled, a deficit that persisted at Day 150 and therefore 
was unlikely due to a temporary delay in differentiation (Figure 14A-H). Quantitative 
analyses revealed that SATB2 and RORB expression patterns were not restricted to the 
upper cortical bins, but instead spanned the entire CP in mDISC1 SNOs (Figure 14B and 
14E). The SATB2+ neurons outnumbered TBR1+ neurons in both the upper and deep 
layers, preventing the establishment of mutually exclusive expression domains between 
the two markers (Figure 14G-H).  
Co-expression between SATB2 and TBR1, and between RORB and CTIP2 were 
increased in mDISC1 SNOs, and the majority of double positive neurons were located in 
the lower part of the CP (Figure 15A-B). These deficits of aberrant laminar distribution 
and elevated marker co-expression phenocopied control SNOs treated with the β-Catenin 
antagonist IWR (Figure 13C-F). Curiously, CUX1 and LAMP5 remained exclusively 
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expressed in the upper layer in mDISC1 SNOs similar to control SNOs, indicating that 
the laminar expression abnormalities did not universally affect all cortical neuron 
subtypes and that LAMP5 and CUX1 expressions were possibly controlled independently 
of SATB2 and RORB. These results point to the model that the cortical disorganization 
observed in mDISC1 SNOs is not caused by a failure of cortical layer formation, but due 
to specifically dysregulated cortical neuron subtype fate specification. 
We previously generated isogenic iPSC lines from the D3 line via genomic 
editing, in which the 4-bp deletion of DISC1 was corrected (D3R iPSC line) (Wen et al., 
2014). At Day 120, the laminar expression patterns of SATB2, TRB1, RORB and CTIP2 
were rescued in D3R SNOs, and their layer-specific distribution depicted a clear 
boundary between the upper and deep cortical layers (Figure 15C-D and 15F-G). The 
ratio of marker co-expression was also restored to the normal level (Figure 15E and 
15H). These results provide evidence that the 4-bp deletion mutation is indeed 








Figure 14. Aberrant Laminar Expression Patterns of Cortical Layers in mDISC1 SNOs 
(A) Sample confocal images of the CP of Control (top) and mDISC1 (bottom) SNOs for 
SATB2 and TBR1 at Day 70, 100, 120 and 150. mDISC1 SNOs displayed extensive 
overlap between the laminar expression patterns of SATB2 and TBR1. Scale bar, 50 µm.  
(B and C) Quantifications of the distribution of SATB2+ and TBR1+ neurons in mDISC1 
SNOs, to be compared with Figure 12B. Values represent mean ± S.E.M. (n = 10 
organoids from D2 and D3 iPSC lines). Also shown in (C) are cumulative distribution 
curves of marker positive neurons at each time point. Kolmogorov-Smirnov tests were 
performed between Control (C) and mDISC1 (D) SNOs for SATB2 (red) and TBR1 
(green) (*p < 0.05, Kolmogorov-Smirnov tests). Same samples as in (B) and Figure 12B.  
(D-F) The laminar distribution of RORB and CTIP2 were similarly disorganized in 
mDISC1 SNOs. Shown in (D) are 100 x 300 µm columns from sample confocal images at 
Day 150. Scale bar, 50 µm. Shown in (E) are quantifications of marker distribution at 
Day 120 and Day 150, to be compared with Figure 12E. Values represent mean ± S.E.M. 
(n = 5 organoids). Shown in (F) are cumulative distribution curves of marker positive 
neurons at each time point. Kolmogorov-Smirnov tests were performed between Control 
(C) and mDISC1 (D) SNOs for RORB (orange) and CTIP2 (blue) (n.s.: p > 0.05, *p < 
0.05, Kolmogorov-Smirnov tests). Same samples as in (E) and Figure 12E.  
(G and H) Comparison of cortical layers between the control SNO and mDISC1 SNO. 
Shown at top are sample tiling confocal images of the CP in Day 150 SNOs. Scale bars, 
200 µm. Shown at bottom are heatmap plots for the differential abundance between 
SATB2+ and TBR1+ in control (E) and in mDISC1 (F) SNOs, similar to Figure 13D. 







Figure 15. Cortical Neuron Fate Specification Deficits Caused by the DISC1 Mutation. 
(A) mDISC1 SNOs showed elevated co-expression between SATB2 and TBR1. Shown on 
the left are sample confocal images at the boundary between upper and deep layers, 
double-positive cells are marked in yellow. Scale bar, 50 µm. Shown on the right is the 
quantification of the ratio of SATB2 and TBR1 co-expression over SATB2+ neurons. 
Same sample as in Figure 14B. Values represent mean ± S.E.M. (***p < 0.0005, 
Student’s t test).  
(B) mDISC1 SNOs also showed elevated co-expression ratio between RORB and CTIP2 
at Day 150. Same sample as in Figure 14E. Values represent mean ± S.E.M. (***p < 
0.0005, Student’s t test).  
(C and D) The layer-specific expression patterns of SATB2 and TBR1 were restored in 
Day 120 SNOs derived from the isogenic D3R iPSC line, in which the DISC1 mutation 
was corrected. Shown in (C) are 100 x 300 µm columns from sample confocal image. 
Scale bar, 50 µm. Shown in (D, left) is the quantification for marker distribution in the 
CP. Values represent mean ± S.E.M. (n = 5 organoids). Shown in (D, right) are 
cumulative distribution curves. Kolmogorov-Smirnov tests were performed between D3R 
and D3 SNOs for SATB2 (red) and TBR1 (green) (*p < 0.05, Kolmogorov-Smirnov tests).  
(E) The ratio of co-expression between SATB2 and TBR1 was restored to normal level in 
D3R SNOs. Same samples as in (D). Values represent mean ± S.D. (***p < 0.0005, 
Student’s t test).  
(F and G) The layer-specific expression patterns of RORB and CTIP2 were restored in 
Day 120 SNOs derived from the isogenic D3R iPSC line. Shown in (F) are 100 x 300 µm 
columns from sample confocal image. Scale bar, 50 µm. Shown in (G, left) is the 
quantification for marker distribution in the CP. Values represent mean ± S.E.M. (n = 5 
organoids). Shown in (G, right) are cumulative distribution curves. Kolmogorov-Smirnov 
tests were performed between D3R and D3 SNOs for RORB (orange) and CTIP2 (blue) 
(*p < 0.05, Kolmogorov-Smirnov tests).  
(H) The ratio of co-expression between RORB and CTIP2 was restored to the normal 
level in D3R SNOs. Same samples as in (G). Values represent mean ± S.D. (***p < 




 5.4 – Discussion 
The most remarkable feature of brain organoids over conventional in vitro 2D 
monolayer or 3D neurosphere models is the ability to recapitulate the elaborate 
architecture of the embryonic human brain via self-organization, which serves as the 
prerequisite for proper maintenance of the neural stem cell niche, neuronal migration, 
cell-cell interactions and circuitry development. Previously published cortical organoid 
systems are generally most representative of early-to-mid gestation human brain 
development and very useful for modeling diseases that are characterized by striking 
structural malformations that manifest early, such as microcephaly and lissencephaly 
(Bershteyn et al., 2017; Qian et al., 2016). However, because no published cortical 
organoid systems to date have consistently shown the formation of distinct cortical 
layers, their utility for investigating late-stage human brain development and disorders is 
uncertain.  
Using a precisely-controlled slicing method to overcome the diffusion barrier and 
prevent interior hypoxia, we address the fundamental limiting factor that has prohibited 
cortical organoids from mimicking the architecture of late-stage human cortical 
development. By exposing progenitor zones to the external culture environment while 
maintaining their structural integrity, the disk-shaped SNOs grow more healthily than 
traditional spherical brain organoids, allowing significantly larger cortical structures to 
emerge. A very recent study reported the use of liquid-air interface culture for cerebral 
organoids, where the additional surface exposure to the external environment led to 
significantly improved neuronal survivability (Giandomenico et al., 2019). While the 
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liquid-air interface culture accelerates neuronal maturation and promotes formation of 
aligned axonal tracks, it also resulted in flattening of the tissue and the VZ and SVZ 
structures were not preserved. In contrast, because we perform the slicing after the 
establishment of VZ and aligned radial glia scaffold, and subsequently return the 
organoid to a 3D suspension culture, this procedure does not disrupt the architectural 
integrity of the progenitor and neuronal layers. Importantly, the radial scaffold provides 
the guiding substrate for neuronal migration to reach the designated laminar location in 
the CP, synergizing with sustained neurogenesis to successfully achieve the formation of 
distinct upper and deep cortical layers in SNOs at later stages. The laminar distributions 
of cortical neuron markers as well as morphologically distinct astrocyte subtypes in Day 
150 SNOs closely resemble their localization in the adult human cerebral cortex and 
properly reflect species-associated differences between human and rodents (Lake et al., 
2016). Moreover, the dramatic reduction in the number of neurons co-expressing upper 
and deep layer markers over time suggests SNOs can recapitulate the human/primate-
specific process of post-mitotic fate specification, which cannot be modeled in rodents.  
We showed that the SNO method is reproducible and generates consistent 
outcomes that can be reliably quantified for multiple iPSC lines. The protocol is simple to 
follow and is compatible for scaling-up. The method may also be applied to organoid 
protocols for other brain regions or other organs as a universal approach to improve cell 
viability and sustain tissue expansion in 3D suspension cultures. Although generation of 
late-stage SNOs is relatively time-consuming, it parallels the natural developmental 
timeline of the human brain as we harness the intrinsic potential, without extensive 
biochemical interference to accelerate its development. By performing systematic 
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characterizations of SNOs at fixed time points from Day 70 to Day 150, we demonstrate 
that the developmental dynamics of SNOs match in vivo corticogenesis at the second and 
early third trimester, and the age of the SNO is a reliable predictor for the corresponding 
maturation stage. The approach does have the caveat of repeated slicing (once per 
month), which may cause some damages to axons and dendrites. However, we keep fairly 
thick sections (500 m) and long-distance axonal process and synaptic connections could 
be maintained in the SNO system. Furthermore, our extracellular recording experiments 
demonstrated repeatable temporal patterns of recruitment and burst durations among 
neurons across long distance in the CP, suggesting that local connectivity remained intact 
despite of repeated slicing. The robust synchronization of spontaneous firing observed in 
SNO highlights its utility for the investigation of network properties in normal and 
disease-related conditions.  
Because the establishment of distinct cortical layers and specification of neuron 
fate occur late in cortical development, the SNO method provides a unique platform to 
investigate phenotypes that cannot be modeled by other current organoid systems. We 
demonstrated the applicability of our system by identifying the critical role of WNT/β-
Catenin signaling in the regulation of postmitotic cortical neuron subtype identities and 
discovering potentially disease-relevant phenotypes in psychiatric disorder patient-
derived organoids. Via suppression of SATB2 and RORB expression, WNT/β-Catenin 
signaling controls the fate specification process pivotal for the establishment of layer-
specific laminar expression patterns. As WNT/β-Catenin signaling is exclusively 
enriched in the deep cortical layers, the resulting SATB2 repression instructs neurons in 
the deep layers, which initially co-express TBR1 and SATB2, to convert into 
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TBR1+/SATB2- deep layer subcortical projection neurons. This fate specification process 
is similarly impaired in both SNOs treated with a β-Catenin inhibitor and in the mDISC1 
SNOs, as indicated by the persistent high level of co-expression between SATB2/TBR1 
and RORB/CTIP2 at Day 120 and Day 150. It remains difficult to determine the extent to 
which our findings mirror the deficits in the patient brains, but it is possible that the 
dysregulation of the laminar expression of neuronal subtype marker genes, as recently 
observed in the brains from children with autism (Stoner et al., 2014), is a novel 
mechanism for abnormal neuronal connectivity and functionality contributing to impaired 
cognitive functions.  
Collectively, the SNO method in the present study delivers a significant advance 
to brain organoid technologies, and provides a platform for systematic and mechanistic 
studies to interrogate late-stage embryonic human brain development that is otherwise 
difficult to address in human fetal tissues or animal models. Laminar structural 
organization, a hallmark of the adult human cortex, is essential for brain functions and its 
dysregulation is implicated in various brain disorders. The formation of distinct cortical 
layers and recapitulation of cortical neuron fate specification in our organoid system 
opens new avenues for the investigation of neuronal organization and circuitry formation 




6 - Conclusions and perspectives 
Tremendous breakthroughs have been made in brain organoid technologies in the past 
few years. While these brain organoids faithfully recapitulate a number of key features of 
the human brain, they are not perfect replica, and overcoming current limitations to 
engineer “better” organoids will greatly expand our ability to investigate human brain 
development and disorders. The definition of “better” organoids may vary based on 
specific applications, but the benchmark is to make organoids that more faithfully 
recapitulate features of the human brain. Therefore, continued systematic characterization 
of human fetal and postnatal brain tissue is fundamental. Despite the difficulty in 
collecting human brain samples with consistent quality, analyses of these samples have 
continued to expand our knowledge of normal and diseased human brains (Calvet et al., 
2016; Hansen et al., 2010; Moore et al., 2017; Nowakowski et al., 2016; Ozair et al., 
2018; Pollen et al., 2015; Stoner et al., 2014). Remarkably, large-scale single-cell 
transcriptome profiling has resulted in unprecedented resolution revealing the extent of 
cellular diversity and molecular identities of the embryonic human brain (Nowakowski et 
al., 2017; Zhong et al., 2018). Pioneered by The Allen Institute for Brain Science, the 
eventual establishment of a comprehensive human brain atlas containing 
immunohistology, in situ hybridization, and transcriptomics data will provide an 
invaluable resource for organoid engineers (Ding et al., 2017).  
The fact that brain organoids dynamically mimic the temporal progression of 
human brain development is both an advantage and disadvantage for researchers. On the 
one hand, brain organoids of different ages recapitulate their corresponding in vivo 
embryogenesis periods, offering researchers a versatile platform to probe different 
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developmental stages.  On the other hand, from a practical point of view, brain organoids 
take a long time to grow and mature, raising the cost and hindering the efficiency of 
experiments. Methods for speeding up the maturation process thus need to be explored. 
For instance, the use of NOTCH inhibitors is very effective in accelerating neuronal 
differentiation in vitro and could be applied to brain organoids. But this poses a dilemma 
because such an intervention could interfere with the intrinsic program of neural 
differentiation, making the resulting organoids no longer representative of their in vivo 
counterparts (Borghese et al., 2010). Furthermore, to faithfully model age-dependent 
neurodegenerative diseases requires inducing aging in organoids by pharmacological or 
genetic methods (Studer et al., 2015). One such strategy for inducing aging-related 
features in human iPSC-derived organoids, used to model PD, involves the expression of 
progerin, a truncated form of Lamin A associated with premature aging (Miller et al., 
2013). Telomere shortening induced via downregulation of telomerase has also been 
shown to result in age-related and disease-relevant phenotypes in human iPSC-derived 
neurons (Vera et al., 2016). However, whether these “induced” aging events accurately 
reflect the aging process that occurs naturally in vivo remains to be determined. 
The introduction of fused organoids or “assembloid” systems opens a path to a 
modular design approach to investigate inter-brain-region and inter-organ crosstalk. 
Assembly of cortical organoids and organoids with subcortical identities, such as the 
thalamus, may offer insights into the development of corticofugal projections of deep 
layer cortical neurons (Pasca, 2018). More complex assembloid systems composed of 
three or more brain regions are feasible, and the ultimate goal is the assembly of a whole-
brain organoid for comprehensive modeling of brain development and function. The 
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combination of organoids from different tissue types could also capture the interface 
between the nervous system and other organs. Such is the case for the recently reported 
hPSC-derived intestinal organoids containing neural crest cells, which self-organize to 
resemble the enteric nervous system and produce rhythmic waves to regulate contraction 
of the organoids (Workman et al., 2017). Moreover, oncogene manipulation using 
CRISPR/Cas9 can be applied to initiate tumorigenesis in human brain organoids as an 
innovative approach to model brain tumors (Bian et al., 2018; Ogawa et al., 2018). 
Alternatively, brain tumor organoids can be generated from primary glioblastoma 
specimens from patients that are dissected into smaller pieces and cultured in 3D 
environment (Hubert et al., 2016). The subsequent fusion of these tumor organoids with 
normal brain organoids may create a scalable in vitro model for cancer metastasis, giving 
the means to screen for therapies that specifically block cancer cells’ invasion into 
surrounding tissue.  
 Lastly, it should be noted that organoid differentiation protocols that rely on the 
self-organization of hPSCs, and stochasticity in their spontaneous differentiation, lead to 
inherently variable outcomes. Therefore, unlike organs that arise from the precisely 
controlled process of in vivo organogenesis, no two organoids are identical. To improve 
the quality control, variables in the system should be eliminated wherever possible 
(Jabaudon and Lancaster, 2018). Feeder-dependent hPSC cultures are more technique-
dependent, and the properties of each hPSC line are sometimes inconsistent. A shift to 
using feeder-free hPSC culture is likely to significantly improve the reproducibility 
across laboratories and cell lines (Lancaster et al., 2017; Nakagawa et al., 2014; Yoon et 
al., 2019). The use of variable ingredients, such as animal-derived ECM (Matrigel), in 
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culture protocols should also be minimized, and recombinant growth factors should be 
replaced by small molecules whenever applicable (Cruz-Acuna et al., 2017; Gjorevski et 
al., 2016). Furthermore, newly developed organoid generation methods need to be 
quantitatively characterized to show consistent results with multiple cell lines and 
independent batches before they are ready for publication. The development of a 
miniaturized multi-well spinning bioreactor has enabled efficient optimization of 
organoid protocols and scalable organoid production (Qian et al., 2016), but current 
methods for organoid characterization are labor-intensive and prevent scaling-up of 
organoid experiments. Moving forward, the development of systems with automated 
read-outs for high-throughput analyses will be instrumental to transform organoid models 
into high-throughput platforms suitable for compound screening and drug discovery.  
Together, the rapid advances in brain organoid technologies have opened up new 
avenues for gaining a better understanding of human brain development, function, 
evolution and disorders. The brain organoid field has made exciting steps to empower 
researchers with new tools to address questions that are difficult to address in other model 
systems, but there remains a long way to go towards obtaining a more faithful in vitro 
representation of the developing human brain. It is important to keep in mind that no 
model is perfect. Only through synergy across different model systems can we truly gain 
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Graduate Student, Johns Hopkins University (PI: Hongjun Song, PhD)    
2014-present 
• Developed a system to generate brain region-specific organoid from human 
pluripotent stem cells using miniaturized multi-well spinning bioreactor, patent 
application pending.  
• Investigated the effects of Zika virus infection in human NPCs and organoids and 
discovered the first experimental evidence for causality between Zika and 
neurological birth defects.  
• Developed methods to generate cortical organoids with expanded laminar structures 
and specified cortical layers representative of late fetal development.  
• Investigated the developmental mechanisms of psychiatric disorders using patient-
derived organoids.  
• Resulted in 11 publications, 4 first author (Cell, Nature Protocols, Development), 1 
co-first author (Cell Stem Cell), and one first author publication in review.  
 
PUBLICATIONS 
1. Jacob F, Salinas RD, Zhang DY, Nguyen PTT, Schnoll JG, Wong SZH, Thokala R, Sheikh 
S, Saxena D, Prokop S, Liu DA, Qian X, Petrov D, Lucas T, Chen HI, Dorsey JF, Christian 
KM, Binder ZA, Nasrallah M, Brem S, O’Rourke DM, Ming GL, Song H. A patient-derived 
glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral 
heterogeneity. Cell. 2020; In press. 
 
2. Qian X, Song H, Ming GL. Brain organoids: advances, applications and challenges. 
Development. 2019; 146(8). PubMed PMID: 30992274. 
 
3. Qian X*, Jacob F*, Song MM, Nguyen HN, Song H, Ming GL. Generation of human brain 
region-specific organoids using a miniaturized spinning bioreactor. Nat Protoc. 
2018;13(3):565-80. PubMed PMID: 29470464. Cover image. 
 
4. Ye F, Kang E, Yu C, Qian X, Jacob F, Yu C, Mao M, Poon RYC, Kim J, Song H, Ming 
GL, Zhang M. DISC1 Regulates Neurogenesis via Modulating Kinetochore Attachment of 





5. Yoon KJ, Song G, Qian X, Pan J, Xu D, Rho HS, Kim NS, Habela C, Zheng L, Jacob F, 
Zhang F, Lee EM, Huang WK, Ringeling FR, Vissers C, Li C, Yuan L, Kang K, Kim S, 
Yeo J, Cheng Y, Liu S, Wen Z, Qin CF, Wu Q, Christian KM, Tang H, Jin P, Xu Z, Qian J, 
Zhu H, Song H, Ming GL. Zika-Virus-Encoded NS2A Disrupts Mammalian Cortical 
Neurogenesis by Degrading Adherens Junction Proteins. Cell Stem Cell. 2017;21(3):349-
58 e6. PubMed PMID: 28826723. 
 
6. Qian X, Nguyen HN, Jacob F, Song H, Ming GL. Using brain organoids to understand Zika 
virus-induced microcephaly. Development. 2017;144(6):952-7. PubMed PMID: 28292840. 
 
7. Xu M, Lee EM, Wen Z, Cheng Y, Huang WK, Qian X, Tcw J, Kouznetsova J, Ogden SC, 
Hammack C, Jacob F, Nguyen HN, Itkin M, Hanna C, Shinn P, Allen C, Michael SG, 
Simeonov A, Huang W, Christian KM, Goate A, Brennand KJ, Huang R, Xia M, Ming GL, 
Zheng W, Song H, Tang H. Identification of small-molecule inhibitors of Zika virus 
infection and induced neural cell death via a drug repurposing screen. Nat Med. 
2016;22(10):1101-7. PubMed PMID: 27571349. Cover image. 
 
8. Zhang F, Hammack C, Ogden SC, Cheng Y, Lee EM, Wen Z, Qian X, Nguyen HN, Li Y, 
Yao B, Xu M, Xu T, Chen L, Wang Z, Feng H, Huang WK, Yoon KJ, Shan C, Huang L, 
Qin Z, Christian KM, Shi PY, Xu M, Xia M, Zheng W, Wu H, Song H, Tang H, Ming GL, 
Jin P. Molecular signatures associated with ZIKV exposure in human cortical neural 
progenitors. Nucleic Acids Res. 2016;44(18):8610-20. PubMed PMID: 27580721. 
 
9. Nguyen HN, Qian X, Song H, Ming GL. Neural stem cells attacked by Zika virus. Cell Res. 
2016;26(7):753-4. PubMed PMID: 27283801. 
 
10. Schiffhauer ES, Luo T, Mohan K, Srivastava V, Qian X, Griffis ER, Iglesias PA, Robinson 
DN. Mechanoaccumulative Elements of the Mammalian Actin Cytoskeleton. Curr Biol. 
2016;26(11):1473-9. PubMed PMID: 27185555. 
 
11. Qian X*, Nguyen HN*, Song MM, Hadiono C, Ogden SC, Hammack C, Yao B, Hamersky 
GR, Jacob F, Zhong C, Yoon KJ, Jeang W, Lin L, Li Y, Thakor J, Berg DA, Zhang C, Kang 
E, Chickering M, Nauen D, Ho CY, Wen Z, Christian KM, Shi PY, Maher BJ, Wu H, Jin 
P, Tang H, Song H, Ming GL. Brain-Region-Specific Organoids Using Mini-bioreactors for 
Modeling ZIKV Exposure. Cell. 2016;165(5):1238-54. PubMed PMID: 27118425. 
 
12. Tang H*, Hammack C*, Ogden SC*, Wen Z*, Qian X*, Li Y, Yao B, Shin J, Zhang F, Lee 
EM, Christian KM, Didier RA, Jin P, Song H, Ming GL. Zika Virus Infects Human Cortical 









1. Qian X, Song H, Ming GL. Sliced Human Cortical Organoids for Modeling Distinct 
Cortical Neuronal Layer Formation. Oral presentation delivered at New York Stem Cell 
Foundation Conference, New York, NY, USA, 2019. 
 
2. Qian X, Song H, Ming GL. Human Sliced Neocortical Organoids Establish Specified Upper 
and Deep Cortical Layers. Poster presentation delivered at International Society for Stem 
Cell Research Annual Meeting, San Diego, CA, USA, 2019.  
 
3. Qian X, Song H, Ming GL. Modeling Human Brain Development and Disorders Using 
hiPSC-derived Organoids. Invited oral presentation delivered at International Young 
Scholar’s Forum at Nanjing Medical University, Nanjing, Jiangsu, China, 2018. 
 
4. Qian X, Song H, Ming GL. Modeling neurodevelopmental etiology of psychiatric disorders 
in human forebrain organoids. Oral presentation delivered at Society for Neuroscience 
meeting, San Diego, CA, USA, 2018.  
 
 
5. Qian X, Song H, Ming GL. Engineering Forebrain Organoids to Model Zika Virus-Induced 
Microcephaly. Invited lecture delivered at Tsinghua University McGovern Institute for 
Brain Research lecture series, Beijing, China, 2016.  
 
6. Qian X, Song H, Ming GL. Engineering Forebrain Organoids to Model Zika Virus-Induced 
Microcephaly. Invited oral presentation delivered at “Hot Topics in Stem Cell Biology” 
Symposium at Society for Neuroscience meeting, San Diego, CA, USA, 2016.  
 
7. Qian X, Nguyen HN, Song MM, Ogden SC, Hammack C, Wen Z, Tang H, Song H, Ming 
GL. Forebrain Organoids Generated Using Mini-bioreactors For Modeling Zika Virus 
Exposure and Microcephaly. Society for Neuroscience abstract: 8702. Poster presentation 





8. Qian X, Nguyen HN, Tang H, Song H, Ming GL. Studying Zika-induced Birth Defects with 
“Mini-brains”. Oral presentation delivered at Neuroscience 2016 Press Conference: Zika 
at Society for Neuroscience meeting, San Diego, CA, USA, 2016.  
 
9. Qian X, Gornet M, Song H, Ming GL. Engineering Mini-Brains to Understand Zika Virus-
Induced Microcephaly. Invited lecture delivered at Johns Hopkins University Partnering 
Toward Discovery lecture series, Baltimore, MD, USA, 2016.  
 
10. Qian X, Nguyen HN, Song MM, Ogden SC, Hammack C, Wen Z, Tang H, Song H, Ming 
GL. Forebrain Organoids Generated Using Mini-bioreactors For Modeling Zika Virus 
Exposure and Microcephaly. Poster presentation at Maryland Stem Cell Research 
Symposium, Bethesda, MD, USA 2016. 
 
11. Qian X, Ming GL, Song H. Generation of Cerebral Cortex Organoids from Human Induced 
Pluripotent Stem Cells. Oral presentation delivered at Johns Hopkins Neuroscience 
Department seminar, Baltimore, MD, USA, 2016.  
 
12. Qian X, Yamajala P, Ambady S, Wen Q. Real-time Analysis of Cell Traction Force in vitro 
on Deformable Hydrogels. Poster presentation at Annual Northeast Bioengineering 





Song H, Ming G, Song MM, Hadiono C, Jeang W, Nguyen NH, Qian X. Cell culture system and 








Teaching assistant, Cellular Engineering, 2016. 
Teaching assistant, Molecules and Cells, 2016. 
 
HONORS AND AWARDS 
2010-2013  Presidential Scholarship, Worcester Polytechnic Institute 
2010-2013  International Scholarship, Worcester Polytechnic Institute 
2011   Charles O. Thompson Scholar Award (5%), Worcester Polytechnic 
Institute 
2012   Undergraduate Research Fellowship, Worcester Polytechnic Institute 
2013   Provost’s Major Qualifying Project Award, Worcester Polytechnic 
Institute 
2013   B.S. awarded with high honors (10%), Worcester Polytechnic Institute 
2016 National Institute of Neurological Disorders and Stroke Travel Award  
2017   Bae Gyo Jung Young Investigator Award, Johns Hopkins University 
2019 Chinese National Award for Outstanding Self-Financed Students 
Abroad, Ministry of Education of the People's Republic of China 
 
